COVID-19 Literature

AAP Committee on Infectious Diseases. COVID-19 vaccines in children and adolescents. Pediatrics (Position paper) 2021 Aug;148(2):e20211052336

Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar. JAMA Netw Open 2021 (published online Nov 1)

Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections. Nat Commun 2022 Jan 27;13(532)

Abu-Raddad LJ, Chemaitelly H, Bitt AA, for the National Study Group for COVID-19 Vaccination. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J Med (Correspondence) 2021 (published online May 5)

Aburto JM, Scholey J, Kashnitsky I, et al. Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries. Int J Epidemiol 2021 (published online Sep 26)

Aceng FL, Ario AR, Alitubeera PH, et al. Cutaneous anthrax associated with handling carcasses of animals that died suddenly of unknown cause: Arua District, Uganda, January 2015–August 2017. PLOS Negl Trop Dis 2021 (published online Aug 23)

Adamoski D, Carvalho de Oliveira J, Bonatto AC, et al. Large-scale screening of asymptomatic persons for SARS-CoV-2 variants of concern and Gamma takeover, Brazil. Emerg Infect Dis 2021 (published online Sep 17)

Adams SH, Schaub JP, Nagata JM, et al. Young adult perspectives on COVID-19 vaccinations. J Adolesc Health 2021 (published online Jul 14)

Ader F, Bouscambert-Duchamp M, Hites M, et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis

Agarwal R, Dugas M, Ramaprasad J, et al. Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination. Proc Natl Acad Sci 2021 Aug 7;118(33):e2107873118

Agarwal R, Dugas M, Ramaprasad J, et al. Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination. Proc Natl Acad Sci USA 2021 (published online Jul 29)

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature 2021 (published online Apr 22)

Albarracin D, Jung H, Song W, et al. Rather than inducing psychological reactance, requiring vaccination strengthens intentions to vaccinate in US populations. Sci Rep 2021 Oct 21;11(20796)

Alfieri NL, Kusma JD, Heard-Garris N, et al. Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot. BMC Public Health 2021 Sep 13;21(1662)

Ali K, Berman G, Zhou H, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med 2021 (published online Aug 11)

Althoff KN, Schlueter DJ, Anton-Culver H, et al. Antibodies to SARS-CoV-2 in All of Us research program participants, January 2–March 18, 2020. Clin Infect Dis 2021 (published online Jun 15

Alvarez-Esteban PC, del Barrio E, Rueda OM, et al. Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain). PLOS One 2021 (published online Sep 20)

Alvarez-Garcia J, Jaladanki S, Rivas-Lasarte M, et al. New heart failure diagnoses among patients hospitalized for COVID-19. J Am Coll Cardiol 2021 May;77(17):2260-2

Alyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021 (published online Jul 15)

Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet (Letter) 2021 (published online Feb 18)

Andersen KM, Bates BA, Rashidi ES, et al. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative. Lancet Rheumatol 2021 (published online Nov 15)

Andrews N, Stower J, Kiresbom F, et al. Effectiveness of BNT162b2 COVID-19 booster vaccine against COVID-19 related symptoms and hospitalization in England. Nat Med 2022 (published online Jan 14)

Annavajhala MK, Mohri H, Wang P, et al. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nat 2021 (published online Aug 24)

Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2021 (published online Sep 1)

Aranda J, Oriol I, Martin M, et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J Infect 2021 (published online Aug 13)

Arolas HP, Acosta E, Lopez-Casasnovas G, et al. Years of life lost to COVID-19 in 81 countries. Sci Rep 2021 Feb 18;11:3504

Ashrani AA, Crusan DJ, Petterson T, et al. Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination. JAMA Intern Med 2021 (published online Nov 1)

Ashworth M, Thunstrom L, Cherry TL, et al. Emphasize personal health benefits to boost COVID-19 vaccination rates. Proc Natl Acad Sci 2021 Aug 10;118(32):e210822511

Asiimwe IG, Pushpakom S, Turner RM, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol 2021 (published online Jun 7)

Atmar RL, Lyke KE, Deming ME, et al. Homologous and heterologous COVID-19 booster vaccinations. N Engl J Med 2022 (published online Jan 26)

Atyeo C, Deriso EA, Davis C, et al. COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and non-pregnant women. Sci Transl Med 2021 (published online Oct 19)

Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med 2021 (published online Apr 1)

Axfors C, Janiaud P, Schmitt AM, et al. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infect Dis 2021 Nov 20;21(1170)

Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ 2021 Mar 31;372:n693

Baack BN, Abad N, Yankey D, et al. COVID-19 vaccination coverage and intent among adults aged 18-39 years—United States, March-May 2021. MMWR 2021 (published online Jun 21)

Badr DA, Picone O, Bevilacqua E, et al. Severe acute respiratory syndrome coronavirus 2 and pregnancy outcomes according to gestational age at time of infection. Emerg Infect Dis 2021 (published online Aug 5)

Bahl A, Johnson S, Maine G, et al. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study. Lancet Reg Health Am 2021 (published online Sep 9)

Bajos N, Spire A, Silberzan L, et al. The social specificities of hostility toward vaccination against COVID-19 in France. PLOS One 2022 (published online Jan 6)

Balasuriya L, Santilli A, Morone J, et al. COVID-19 vaccine acceptance and access among Black and Latinx communities. JAMA Netw Open 2021 Oct 13;4(10):e2128575

Bar-On YM, Goldberg Y, Mandel M, et al. Protection against COVID-19 by BNT162b2 booster across age groups. N Engl J Med 2021 (published online Dec 8)

Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med 2021 (published online Sep 15)

Barbieri PN, Giuntella O, Saccardo S, et al. Lifestyle and mental health 1 year into COVID-19. Sci Rep 2021 Dec 2;11(23349)

Barboza JJ, Chambergo-Michilot D, Velasquez-Sotomayor M, et al. Assessment and management of asymptomatic COVID-19 infection: a systematic review. Travel Med Infect Dis 2021 (published online Apr 7)

Barda N, Daga N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med 2021 (published online Aug 25)

Barham HP, Tha MA, Broyles S, et al. Association between bitter taste receptor phenotype and clinical outcomes among patients with COVID-19. JAMA Netw Open 2021 May 25;1;4(5):e2111410

Barnwal P, Yao Y, Wang Y, et al. Assessment of excess mortality and household income in rural Bangladesh during the COVID-19 pandemic in 2020. JAMA Netw Open 2021 (published online Nov 15)

Barrett CE, Koyama AK, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years — United States, March 1, 2020–June 28, 2021. MMWR Morb Mortal Wkly Rep 2022 Jan 14;71(2):59-65

Barrett CE, Koyama AK, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years—United States, March 1, 2020–June 28, 2021. MMWR Morb Mortal Wkly Rep 2022 (published online Jan 7)

Barry V, Dasgupta S, Weller DL, et al. Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity—United States, December 14, 2020–May 1, 2021. MMWR May 28;70

Bart SM, Harizaj A, Pearson CL, et al. SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member – Connecticut, July–August 2021. Clin Infect Dis 2021 (published online Dec 10)

Bartoletti M, Azap O, Barac A, et al. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect 2021 (published online Nov 21)

Bassolas A, Sousa S, Nicosia V. Diffusion segregation and the disproportionate incidence of COVID-19 in African American communities. J R Soc Interface 2021 (published online Jan 27)

Bean DJ, Monroe J, Turcinovic J, et al. SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies. Clin Infect Dis 2021 (published online Nov 10)

Beauchamp MK, Joshi D, McMillan J, et al. Assessment of functional mobility after COVID-19 in adults aged 50 years or older in the Canadian longitudinal study on aging. JAMA Netw Open 2022;5(1):e2146168

Bell ML, Catalfamo CJ, Farland LV, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLOS One 2021 (published online Aug 4)

Bellon M, Baggio S, Bausch FJ, et al. SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults. Clin Infect Dis 2021 (published online May 5)

Ben S, Xin J, Chen S, et al. Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks. J Infect 2021 (published online Nov 9)

Bergqvist R, Ahlqvist VH, Lundberg M, et al. HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: a registry-based cohort study. PLOS Med 2021 (published online Oct 14)

Bergwerk M, Gonen T, Lustig Y, et al. COVID-19 breakthrough infections in vaccinated health care workers. N Engl J Med 2021 (published online Jul 28)

Bernal JL, Andrews N, Gower C, et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in the UK: a test negative case control study. Public Health England (preprint) 2021

Bernal JL, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med 2021 (published online Jul 21)

Bierle DM, Ganesh R, Tulledge-Scheitel S, et al. Monoclonal antibody treatment of breakthrough COVID-19 in fully vaccinated individuals with high-risk comorbidities. J Infect Dis 2021 (published online Nov 16)

Bilal U, Tabb LP, Barber S, et al. Spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in 3 U.S. cities. Ann Intern Med 2021 (published online Mar 30)

Birhane M, Bressler S, Chang G, et al, for the CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021. MMWR 2021 May 25;70

Blumenthal KG, Robinson LB, Camargo CA Jr, et al. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA 2021 (published online Mar 8)

Bo XU, Fu-qiang MA, Cong HE, et al. Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China. J Infect 2022 (published online Jan 1)

Boehmer TK, Kompaniyets L, Lavery AM, et al. Association between COVID-19 and myocarditis using hospital-based administrative data—United States, March 2020–January 2021. MMWR Morb Mortal Wkly Rep 2021 (published online Aug 31)

Boon SS, Wong MCS, Ng RWY, et al. Seroprevalence of unidentified SARS-CoV-2 infection in Hong Kong during 3 pandemic waves. JAMA Netw Open 2021 (published online Nov 15)

Borchering RK, Viboud C, Howerton E, et al. Modeling of future COVID-19 cases, hospitalizations, and deaths, by vaccination rates and nonpharmaceutical intervention scenarios —US, Apr–Sept 2021. MMWR 2021 May 5;70

Borman AM, Fountain H, Guy R, et al. Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England. J Infect 2022 (published online Jan 4)

Boshier FAT, Venturini C, Stirrup O, et al. The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study. J Infect 2021 (published online Oct 2)

Bourguignon A, Arnold DM, Warkentin TE, et al. Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia. N Engl J Med 2021 (published online Jun 9)

Boyapati A, Wipperman MF, Ehmann PJ, et al. Baseline SARS-CoV-2 viral load is associated with COVID-19 disease severity and clinical outcomes: post-hoc analyses of a phase 2/3 trial. J Infect Dis 2021 (published online Sep 8)

Boyton RJ, Altmann DM. Risk of SARS-CoV-2 reinfection after natural infection. Lancet 2021 (published online Mar 17)

Bress AP, Cohen JB, Anstey E, et al. Inequities in hypertension control in the United States exposed and exacerbated by COVID‐19 and the role of home blood pressure and virtual health care during and after the COVID‐19 pandemic. J Am Heart Assoc 2021 (published online May 19)

Breza E, Stanford FC, Alsan M, et al. Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial

Brihn A, Chang J, OYong K, et al. Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV-2 in a hospital setting—Los Angeles County, California, June-August 2020. MMWR 2021 May 14;70(19):702-6

Brinkley-Rubinstein L, LeMasters K, Nguyen P, et al. The association between intersystem prison transfers and COVID-19 incidence in a state prison system. PLOS One 2021 (published online Aug 12)

Bronstein MV, Kummerfeld E, MacDonald A, et al. Willingness to vaccinate against SARS-CoV-2: the role of reasoning biases and conspiracist ideation. Vaccine 2021 (published online Dec 4)

Brooks JT, Beezhold DH, Noti JD, et al. Maximizing fit for cloth and medical procedure masks to improve performance and reduce SARS-CoV-2 transmission and exposure, 2021. MMWR 2021 Feb 10;70

Brosseau LM, Escandon K, Ulrich AK, et al. SARS-CoV-2 dose, infection, and disease outcomes for COVID-19 – a review. Clin Infect Dis 2021 (published online Oct 15)

Broughel J, Kotrous M. The benefits of coronavirus suppression: a cost-benefit analysis of the response to the first wave of COVID-19 in the United States. PLOS One 2021 (published online Jun 3)

Brown CM, Vostok J, Johnson H, et al. Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings—Barnstable County, Massachusetts, July 2021. MMWR 2021 Jul 30;70

Brown KA, Soucy JP, Buchan SA, et al. The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada. CMAJ 2021 (published online Apr 7)

Browne S, Feemster K, Shen A, et al. COVID-19 vaccine hesitancy among physicians, physician assistants, nurse practitioners, and nurses in two academic hospitals in Philadelphia. Infect Control Hosp Epidemiol 2021 (published online Sep 20)

Bruxvoort KJ, Sy LS, Qian L, et al. Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: interim results from a prospective observational cohort study. Lancet Reg Health Am 2021 (published online Nov 25)

Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions. Vaccine 2021 (published online Jul 23)

Burkholder B, Wadood Z, Kassem A, et al. The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities. Vaccine 2021 (published online Oct 22)

Butler-Laporte G, Nakanishi T, Mooser V, et al. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: a Mendelian randomization study. PLOS Med 2021 (published online Jun 1)

Butt AA, Nafady-Hego H, Chemaitelly H, et al. Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination. Int J Infect Dis 2021 (published online Aug 7)

Butt AA, Omer SB, Yan P, et al. SARS-CoV-2 vaccine effectiveness in a high-risk national population in a real-world setting. Ann Intern Med 2021 (published online Jul 20)

Butt AA, Yan P, Shaikh OB, et al. Rate and risk factors for severe/critical disease among fully vaccinated persons with breakthrough SARS-CoV-2 infection in a high-risk national population. Clin Infect Dis 2021 (published online Dec 10)

Bye AP, Hoepel W, Mitchell JL, et al. Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets. Blood 2021 (published online Jul 28)

Calderon-Parra J, Munez-Rubio E, Fernandez-Cruz A, et al. Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies. Clin Infect Dis 2021 (published online Aug 12)

Campitelli MA, Bronskill SE, Maclagan LC, et al. Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada. JAMA Netw Open 2021 Aug 2;4(8):e2118441

Canas LS, Sudre CH, Pujol JC, et al. Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study. Lancet Digit Health 2021 (published online Jul 29)

Caniels TG, Bontjer I, Van Der Straten K, et al. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination. Sci Adv 2021 Sep 3;7(36)

Capodilupo ER, Miller DJ, et al. Changes in health promoting behavior during COVID-19 physical distancing: utilizing wearable technology to examine trends in sleep, activity, and cardiovascular indicators of health. PLOS One 2021 (published online Aug 12)

Carapito R, Li R, Helms J, et al. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med 2021 (published online Oct 26)

Causey K, Fullman N, Sorensen RJ, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet 2021 (published online Jul 14)

Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 2022 (published online Jan 25)

Chagas ETC, Barros PH, Cardoso-Pereira I, et al. Effects of population mobility on the COVID-19 spread in Brazil. PLOS One 2021 (published online Dec 7)

Challen R, Brooks-Pollock E, Read JM, et al. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ 2021 Feb 25;372:n579

Chang SE, Feng A, Meng W, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 2021 Sep 14;12(5417)

Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA (Insights) 2021 (published online Apr 5)

Chatterjee NA, Jensen PN, Harris AW, et al. Admission respiratory status predicts mortality in COVID-19. Influenza Other Respir Viruses 2021 (published online May 24)

Chau NVV, Ngoc NM, Nguyet LA, et al. An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam. EClinicalMedicine 2021 (published online Sep 29)

Chauhan L, Pattee J, Ford J, et al. A multi-center, prospective, observational-cohort controlled study of clinical outcomes following COVID-19 convalescent plasma therapy in hospitalized COVID-19 patients. Clin Infect Dis 2021 (published online Sep 21)

Chavez-MacGregor M, Lei X, Zhao H, et al. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol 2021 (published online Oct 28)

Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 2021 (published online Oct 6)

Chen AT, Yun H, Ryskina KL, et al. Nursing home characteristics associated with resident COVID-19 morbidity in communities with high infection rates. JAMA Netw Open 2021 Mar 16;4(3):e211555

Chen RE, Zhang X, Case JB, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med 2021 (published online Mar 4)

Chen X, Chen Z, Azman A, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health 2021 (published online Mar 8)

Chen X, Li Y, Shao TR, et al. Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: a multi-center longitudinal study. Influenza Other Respir Viruses 2021 (published online Nov 19)

Cheng WA, Turner L, Marentes Ruiz CJ, et al. Clinical manifestations of COVID-19 differ by age and obesity status. Influenza Other Respir Viruses 2021 (published online Oct 19)

Chevinsky JR, Tao G, Lavery AM, et al. Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data—United States, March 1–June 30, 2020. Clin Infect Dis 2021 (published online Apr 28)

Chodick G, Tene L, Patalon T, et al. Assessment of effectiveness of 1 dose of BNT162b2 vaccine for SARS-CoV-2 infection 13 to 24 days after ionization. JAMA Netw Open 2021 Jun 7;4(6):e2115985

Chodick G, Tene L, Rotem RS, et al. The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data. Clin Infect Dis 2021 (published online May 17)

Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 2021 Apr;132(4):930-41

Chow JH, Yin Y, Yamane DP, et al. Association of pre-hospital antiplatelet therapy with survival in patients hospitalized with COVID-19: a propensity score-matched analysis. J Thromb Haemost 2021 (published online Aug 29)

Chow KC, Aslam A, McClure T, et al. Risk of healthcare-associated transmission of SARS-CoV-2 in hospitalized cancer patients. Clin Infect Dis 2021 (published online July 30)

Christie A, Brooks JT, Hicks LA, et al. Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. MMWR 2021 Jul 27;70

Christie A, Henley J, Mattocks L, et al. Decreases in COVID-19 cases, emergency department visits, hospital admissions, and deaths among older adults following the introduction of COVID-19 vaccine—United States, September 6, 2020–May 1, 2021. MMWR 2021 Jun 8;70

Christophers B, Nieblas-Bedolla E, Gordon-Elliot JS, et al. Mental health of US medical students during the COVID-19 pandemic. J Gen Intern Med 2021 (published online Aug 5)

Chua GT, Kwan MTW, Chui CSL, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination. Clin Infect Dis 2021 (published online Nov 28)

Chudasama DY, Flannagan J, Collin SM, et al. Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England. J Infect 2021 (published online Apr 29)

Chugg B, Lu L, Ouyang D, et al. Evaluation of allocation schemes of COVID-19 testing resources in a community-based door-to-door testing program. JAMA Health Forum 2021 Aug 27;2(8):e212260

Chung SC, Marlow S, Tobias N, et al. Lessons from countries implementing find, test, trace, isolation and support policies in the rapid response of the COVID-19 pandemic: a systematic review. BMJ Open 2021 Jun 29;11(7)

Coggins SA, Laing ED, Olsen CH, et al. Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers. Open Forum Infect Dis 2021 (published online Nov 20)

Coleman KK, Tay DJW, Tan KS, et al. Viral load of SARS-CoV-2 in respiratory aerosols emitted by COVID-19 patients while breathing, talking, and singing. Clin Infect Dis 2021 (published online Aug 6)

Collier DA, De Marco A, Ferreira IA, et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature 2021 (published online Mar 11)

COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021 (published online Mar 17)

Committee on Infectious Diseases. COVID-19 vaccines in children and adolescents. Pediatrics 2021 (published online Dec 20)

Conlon A, Ashur C, Washer L, et al. Impact of the influenza vaccine on COVID-19 infection rates and severity. 2021 Am J Infect Control (published online Feb 22)

Connors JM, Brooks MM, Sciurba FC, et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19. JAMA 2021 (published online Oct 11)

Cooper MH, Christensen PA, Salazar E, et al. Real-world assessment of 2,879 COVID-19 patients treated with monoclonal antibody therapy: a propensity score-matched cohort study. Open Forum Infect Dis 2021 (published online Oct 8)

Corchado-Garcia J, Zemmour D, Hughes T, et al. Analysis of the effectiveness of the Ad26.COV2.S adenoviral vector vaccine for preventing COVID-19. JAMA Netw Open 2021 Nov 2;4(11)e2132540

Corey L, Beyrer C, Cohen MS, et al. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med 2021 (pubished online Aug 5)

Corona A, Richini G, Simoncini S, et al. Treating critically ill patients experiencing SARS-CoV-2 severe infection with Ig-M and Ig-A enriched Ig-G infusion. Antibiotics 2021 Jul 30;10(8):930

Cortez C, Mansour O, Qato DM, et al. Changes in short-term, long-term, and preventive care delivery in US office-based and telemedicine visits during the COVID-19 pandemic. JAMA Health Forum 2021 Jul 9;2(7):e211529

Costa R, Bueno F, Albert E, et al. Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults. Clin Microbiol Infect 2021 (published online Aug 8)

Cot C, Cacciapaglia G, Islind AS, et al. Impact of US vaccination strategy on COVID-19 wave dynamics. Sci Rep 2021 May 26;11:10960

Hause AM, Gee J, Baggs J, et al. COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. MMWR 2021 Jul 30:70

COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol 2021 (published online Oct 5)

Cowling BJ, Lim WW, Cobey S. Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality. Nat Med (Correspondence) 2021 (published online Jul 5)

Dagan N, Barda N, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med 2021 (published online Sep 7)

Dagan N, Barda N, Depten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021 (published online Feb 24)

Dai H, Saccardo S, Han MA, et al. Behavioral nudges increase COVID-19 vaccinations. Nature 2021 (published online Aug 2)

Dainton C, Hay A. Quantifying the relationship between lockdowns, mobility, and effective reproduction number (Rt) during the COVID-19 pandemic in the Greater Toronto Area. BMC Public Health 2021 (published online Sep 11)

Daly M, Jones A, Robinson E. Public trust and willingness to vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021. JAMA (Research letter) 2021 (published online May 24)

Damialis A, Gilles S, Sofiev M, et al. Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe. Proc Natl Acad Sci 2021 Mar 23;118(12):e2019034118

Daniel CL, Williams J, Legg R, et al. Factors associated with COVID-19 vaccination intentions among adults in the deep South. Vaccine 2022 (published online Jan 10)

Danion F, Letscher-Bru V, Guitard J, et al. COVID-19 associated mucormycosis in France: a rare but deadly complication. Open Forum Infect Dis 2021 (published online Nov 6)

Darwin DJ, Bandoy R, Weimer BC. Analysis of SARS-CoV-2 genomic epidemiology reveals disease transmission coupled to variant emergence and allelic variation. Sci Rep 2021 Apr 1;11:7380

Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2021 May 19;373:n1098

Dave D, Friedson AI, Hansen B, et al. Association between statewide COVID-19 lottery announcements and vaccinations. JAMA Health Forum 2021 Oct 15;2(10):e213117

David SSB, Potasman I, Rahamim-Cohen D, et al. Rate of recurrent Guillain-Barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA Neurol 2021 (published online Sep 1)

Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 2021 (published online Mar 3)

Davies NG, Jarvis CI, CMMID COVID-19 Working Group, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 2021 (published online Mar 15)

Davies P, du Pre P, Lillie J, et al. One-year outcomes of critical care patients post–COVID-19 multisystem inflammatory syndrome in children. JAMA Pediatr 2021 (published online Aug 30)

Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021 (published online Jul 15)

Dawood FS, Porucznik CA, Verguilla V, et al. Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City, New York. JAMA Pediatr 2021 (published online Oct 8)

De Giorgi V, West KA, Henning AN, et al. Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection. J Infect Dis 2021 (published online Jun 5)

De Santis GC, Oliveira LC, Garibaldi PMM, et al. High-dose convalescent plasma for treatment of severe COVID-19. Emerg Infect Dis 2022 (published online Jan 26)

DeBiasi RL, Harahsheh AS, Srinivasalu H, et al. Multisystem inflammatory syndrome of children: sub-phenotypes, risk factors, biomarkers, cytokine profiles and viral sequencing. J Pediatr 2021 (published online Jun 25)

Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet 2021 (published online Dec 20)

Delaugerre C, Foissac F, Abdoul H, et al. Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial. Lancet Infect Dis 2021 (published online Nov 26)

Delaune D, Hul V, Karlsson EA, et al. A novel SARS-CoV-2 related coronavirus in bats from Cambodia. Nat Commun 2021 Nov 9;12(6563)

Delaune D, Hul V, Karlsson EA, et al. A novel SARS-CoV-2 related coronavirus in bats from Cambodia. Nat Commun 2021 Nov 9;12(6563)

Delgado MK, Morgan AU, Asch DA, et al. Comparative effectiveness of an automated text messaging service for monitoring COVID-19 at home. Ann Intern Med 2021 (published online Nov 16)

Denny S, Abdolrasouli A, Elamin T, et al. A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave. J Infect 2021 (published online Feb 17)

Desai D, Khan AR, Soneja M, et al. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. Lancet Infect Dis 2021 (published online Nov 23)

Diesel J, Sterrett N, Dasgupta S, et al. COVID-19 vaccination coverage among adults—United States, December 14, 2020–May 22, 2021. MMWR 2021 (published online Jun 21)

Dietrich WL, Bennett JS, Jones BW, et al. Laboratory modeling of SARS-CoV-2 exposure reduction through physically distanced seating in aircraft cabins using bacteriophage aerosol—November 2020. MMWR 2021 Apr 14;70

Dixon BC, Fischer RSB, Zhao H, et al. Contact and SARS-CoV-2 infections among college football athletes in the Southeastern Conference during the COVID-19 pandemic. JAMA Netw Open 2021 Oct 29;4(10):e2135566

Donnino MW, Moskowitz A, Thompson GS, et al. Comparison between patients hospitalized with influenza and COVID-19 at a tertiary care center. J Gen Intern Med 2021 (published online Mar 18)

Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol 2021 (published online May 7)

Driggin E, Morris AA, Maddox TM, et al. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization. J Am Coll Cardiol 2021 (published online Feb 12)

Dryden-Peterson S, Velasquez GE, Stopka TJ, et al. Disparities in SARS-CoV-2 vaccination-to-infection risk during the COVID-19 pandemic in Massachusetts. JAMA Health Forum 2021 Sep 17;2(9):e212666

Dugas M, Grote-Westrick T, Vollenberg R, et al. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). Int J Infect Dis 2021 (published online Feb 22)

Dupuis C, de Montmollin E, Buetti N, et al. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: a multicenter cohort study of the OUTCOMEREA network. PLOS One 2021 (published online Aug 4)

Ebinger JE, Fert-Bober J, Printsev I, et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med 2021 (published onoline Apr 1)

Edara VV, Hudson WH, Xie X, et al. Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination. JAMA (Research letter) 2021 (published online Mar 19)

Ehrmann S, Li J, Ibarra-Estrada M, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med 2021 (published online Aug 20)

El Guerche-Seblain C, Chakir L, Nageshwaran G, et al. Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: mitigation strategies and epidemiology outcomes. Travel Med Infect Dis 2021 (published online Oct 12)

Eliakim-Raz N, Leibovici-Weisman Y, Stemmer A, et al. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged ≥60 years. JAMA Netw Open 2021 (published online Nov 5)

Elias C, Sekri A, Leblanc P, et al. Incubation period of COVID-19: a meta-analysis. Int J Infect Dis 2021 (published online Feb 2)

Elliott J, Whitaker M, Bodinier B, et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLOS Med 2021 (published online Sep 28)

Emary KR, Golubchik T, Aley PK, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet 2021 (published online Mar 30)

Emery T, Koops JC. The impact of COVID-19 on fertility behaviour and intentions in a middle income country. PLOS One 2022 (published online Jan 6)

Epelboin S, Labrosse J, De Mouzon J, et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: a national retrospective cohort study. PLOS Med 2021 (published online Nov 30)

Epsi NJ, Richard SA, Laing ED, et al. Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries. J Infect Dis 2021 (published online Jul 31)

Erol N, Alpinar A, Erol C, et al. Intriguing new faces of COVID-19: persisting clinical symptoms and cardiac effect in children. Cardiol Young 2021 (published online Aug 19)

Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021 (published online Oct 7)

Evans RA, McAuley, Harrison EM, et al (PHOSP-COVID Collaborative Group. Physical, cognitive and mental health impacts of COVID-19 following hospitalization—a multi-centre prospective cohort study. medRxiv (Preprint study) 2021 (published online Mar 24)

Eyre DW, Taylor D, Purver M, et al. Effect of COVID-19 vaccination on transmission of alpha and delta variants. N Engl J Med 2022 (published online Jan 5)

Harrison NE, Ehrman RR, Curtin A, et al. Factors associated with voluntary refusal of emergency medical system transport for emergency care in Detroit during the early phase of the COVID-19 pandemic. JAMA Netw Open 2021 (published online Aug 20)

Fazio RJ, Ruisch BC, Moore CA, et al. Social distancing decreases an individual's likelihood of contracting COVID-19. Proc Natl Acad Sci 2021 Feb 23;118(8):e2023131118

Feld JJ, Kandel C, Biondi MJ, et al. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med 2021 (published online Feb 5)

Feldstein LR, Tenforde MW, Griedman KG, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021 (published online Feb 24)

Feng C, Shi J, Fan Q, et al. Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery. Nat Commun 2021 Aug 17;12(4984)

Finelli L, Gupta V, Petigara T, et al. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open 2021 Apr 8;4(4):e216556

Firestone MJ, Lorentz AJ, Meyer S, et al. First identified cases of SARS-CoV-2 variant P.1 in the United States—Minnesota, January 2021. MMWR 2021 Mar 3;70

Fisman DN, Tuite AR. Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada. CMAJ 2021 (published online Oct 4)

Folmer CPR, Brownlee MA, Fine AD, et al. Social distancing in America: understanding long-term adherence to COVID-19 mitigation recommendations. PLOS One 2021 (published online Sep 24)

Fond G, Nemani K, Etchecopar-Etchart D, et al. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry 2021 (published onoline Jul 27)

Foote MB, White JR, Jee J, et al. Association of antineoplastic therapy with decreased SARS-CoV-2 infection rates in patients with cancer. JAMA Oncol 2021 (published online Aug 19)

Fowlkes A, Gaglani M, Groover K, et al. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (delta) variant predominance—eight U.S. locations, December 2020–August 2021. MMWR Morb Mortal Wkly Rep 2021 (published online Aug 24)

French G, Hulse M, Nguyen D, et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic — United States, July 2020–July 2021. MMWR Morb Mortal Wkly Rep 2021 Nov 19;70(46):1613-6

Frenck RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med 2021 (published online May 27)

Fu C, Stoeckle JH, Masri L, et al. COVID-19 outcomes in hospitalized patients with active cancer: experiences from a major New York City health care system. Cancer 2021 (published online Jun 7)

Fujino T, Nomoto H, Kutsuna S, et al. Novel SARS-CoV-2 variant identified in travelers from Brazil to Japan. Emerg Infect Dis (Research letter) 2021 Apr;27(4)

Funk AL, Florin TA, Kuppermann N, et al. Outcomes of SARS-CoV-2–positive youths tested in emergency departments: the global PERN–COVID-19 study. JAMA Netw Open 2022;5(1):e2142322

Galvani A, Moghadas SM, Schneider EC. Deaths and hospitalizations averted by rapid U.S. vaccination rollout. Issue Brief (Commonw Fund) 2021 (published online Jul 7)

Gangneux JP, Dannaoui E, Fekkar A, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 2021 (published online Nov 26)

Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol 2021 (published online Apr 28)

Gao Y, Chen Y, Liu M, et al. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis. Epidemiol Infect 2021 (published online Feb 15)

Garcia P, Montez-Rath ME, Moore H, et al. SARS-CoV-2 vaccine acceptability in patients on hemodialysis: a nationwide survey. J Am Soc Nephrol (Rapid communication) 2021 (published online Apr 29)

Garcia-Beltran WF, Lam EC, Denis K, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 2021 (published online Mar 12)

Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. MMWR 2021 (published online Jul 6)

Garibaldi BT, Wang K, Robinson ML, et al. Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19. JAMA Netw Open 2021 Mar 24;4(3):e213071

Ge E, Li Y, Wu S, et al. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: a population-based cohort study. PLOS One 2021 (published online Oct 5)

Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR 2021 Feb 19;70

Geng EH, Schwab J, Foraker R, et al. Outcomes associated with social distancing policies in St. Louis, Missouri, during the early phase of the COVID-19 pandemic. JAMA Netw Open 2021 (published online Sep 1)

Geriatric Medicine Research Collaborative. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age Ageing 2021 (published online Feb 5)

Gershengorn HB, Patel S, Shukla B, et al. Association of race and ethnicity with COVID-19 test positivity and hospitalization is mediated by socioeconomic factors. Ann Am Thorac Soc 2021 (published online Mar 15)

Ghanei M, Solaymani-Dodaran M, Qazvini A, et al. The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial. Respir Res 2021 Sep 15;22(245)

Gharpure R, Guo A, Bishnoi CK, et al. Dose vaccination coverage among residents and staff members of skilled nursing facilities participating in the pharmacy partnership for long-term care program—United States, December 2020–January 2021. MMWR 2021 Feb 1;70

Gharpure R, Sami S, Vostok J, et al. Multistate outbreak of SARS-CoV-2 infections, including vaccine breakthrough infections, associated with large public gatherings, United States. Emerg Infect Dis 2021 (published online Nov 18)

Glatman-Freedman A, Hershkovitz Y, Kaufman Z, et al. Effectiveness of BNT162b2 vaccine in adolescents during outbreak of SARS-CoV-2 Delta variant infection, Israel, 2021. Emerg Infect Dis 2021 (published online Sep 27)

Gleason J, Ross W, Fossi A, et al. The devastating impact of Covid-19 on individuals with intellectual disabilities in the United States. NEJM Catal Innov Care Deliv 2021 Mar 5;2(3)

Glenet M, Lebreil AL, Heng L, et al. Asymptomatic COVID-19 adult outpatients identified as significant viable SARS-CoV-2 shedders. Sci Rep 2021 Oct 18;11(20615)

Global Fund. The impact of COVID-19 on HIV, TB and malaria services and systems for health: a snapshot from 502 health facilities across Africa and Asia. Geneva Switzerland: The Global Fund to Fight AIDS Tuberculosis and Malaria, Apr 2021

Gold JA, Gettings JR, Kimball A, et al. Clusters of SARS-CoV-2 infection among elementary school educators and students in one school district—Georgia, December 2020–January 2021. MMWR 2021 Feb 22;70

Gold JE, Okyay RA, Licht WE, et al. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 2021 Jun 17;106(6):763

Goldszmidt R, Petherick A, Andrade EB, et al. Protective behaviors against COVID-19 by individual vaccination status in 12 countries during the pandemic. JAMA Netw Open 2021 (published online Oct 26)

Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with COVID-19. N Engl J Med 2021 (published online Aug 4)

Gomes D, Beyerlein A, Katz K, et al. Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany. PLOS One 2021 (published online Nov 5)

Gomes D, Beyerlein A, Katz K, et al. Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany. PLOS One 2021 (published online Nov 5)

Gorga SM, Brandt EJ, Rosenberg J, et al. Youth perceptions of vaccination for COVID-19 in the United States. JAMA 2021 (published online Aug 20)

Gostin LO, Shaw J, Salmon DA. Mandatory SARS-CoV-2 vaccinations in K-12 schools, colleges/universities, and businesses. JAMA (Viewpoint) 2021 (published online Jun 7)

Goupil R, Benlarbi M, Beaubien-Souligny W, et al. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis. CMAJ 2021 (published online May 12)

Government Accountability Office. COVID-19: Continued attention needed to enhance federal preparedness, response, service delivery, and program integrity. GAO-21-551. Washington, DC: GAO, Jul 19, 2021

Government Accountability Office. COVID-19: efforts to increase vaccine availability and perspectives on initial implementation. Washington, DC: GAO, 2021 Apr 14

Government Accountability Office. Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog. GAO 2021 (published online Mar 4)

Government Accountability Office. VA COVID-19 procurements: pandemic underscores urgent need to modernize supply chain. GAO-21-280. 2021 (published online Jun 15)

Government Accountability Office. VA Veterans Community Care Program: VA took action on veterans' access to care, but COVID-19 highlighted continued scheduling challenges. GAO-21-476. Washington, DC: GAO, 2021 Jun 28

Graff K, Smith C, Silveira L, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J 2021 Apr;40(4):e137-45

Gram MA, Nielsen J, Schelde AB, et al. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: a nationwide population-based cohort study. PLOS Med 2021 (published online Dec 17)

Gray KJ, Bordt EA, Alyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021 (published online Mar 25)

Greenhalgh T, Jimenez JL, Prather KA, et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet (Comment) 2021 (published online Apr 15)

Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021 (published online Apr 9)

Grint DJ, Wing K, Williamson E, et al. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Eurosurveill 2021 Mar 18;26(11)

Grumbach K, Judson T, Desai M, et al. Association of race/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay area. JAMA Intern Med (Research letter) 2021 (published online Mar 30)

Grunau B, Asamoah-Boaheng M, Lavoie PM, et al. A higher antibody response is generated with a 6- to 7-week (vs standard) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine dosing interval. Clin Infect Dis 2021 (published online Nov 30)

Grunau B, Goldfarb DM, Asamoah-Boaheng M, et al. Immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals. JAMA 2021 (published online Dec 3)

Gu H, Chu DKW, Chang LDJ, et al. Genetic diversity of SARS-CoV-2 among travelers arriving in Hong Kong. Emerg Infect Dis 2021 (published online Aug 23)

Gu H, Cirillo C, Nabeebaccus AA, et al. First-phase ejection fraction, a measure of preclinical heart failure, is strongly associated with increased mortality in patients with COVID-19. Hypertension 2021 (published online May 10)

Guerrero JI, Barragan LA, Martinez JD, et al. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021 Jun 2;21:515

Guerson-Gil A, Palaiodimos L, Assa A, et al. Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York. Euro J Clin Microbiol Infect Dis 2021 (published online May 6)

Guglielmetti L, Aschieri D, Kontsevaya I, et al. Treatment for COVID-19—a cohort study from Northern Italy. Sci Rep 2021 Oct 25;11(20964)

Guy GP, Lee FC, Sunshine G, et al. Association of state-issued mask mandates and allowing on-premises restaurant dining with county-level COVID-19 case and death growth rates—United States, March 1–December 31, 2020. MMWR 2021 Mar 5;70

Haas EJ, Angulo F, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021 (published online May 5)

Hacisuleyman E, Hale C, Saito Y, et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 2021 (published online Apr 21)

Hall VJ, Fouldes S, Sael A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet 2021 (published online Apr 23)

Han X, Xu J, Hou H, et al. Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: evidence based on a meta-analysis. J Infect 2021 (published online Nov 29)

Han X, Xu Y, Fan L, et al. Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries. Proc Natl Acad Sci 2021 Aug 3;118(31):e2100201118
COV HP

Hanson KE, Altayar O, Caliendo AM, et al. The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clin Infect Dis 2021 (published online Jun 23)

Harder T, Kulper-Schiek W, Reda S, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021. Euro Surveill 2021 Oct 14;26(41)

Harvey RA, Rassen JA, Kabelac CA, et al. Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med 2021 (published online Feb 24)

Hast M, Swanson M, Scott C, et al. Prevalence of risk behaviors and correlates of SARS-CoV-2 positivity among in-school contacts of confirmed cases in a Georgia school district in the pre-vaccine era, December 2020–January 2021. BMC Public Health 2022 Jan 14;22(101)

Havers FP, Whitaker M, Self JL, et al. Hospitalization of adolescents aged 12-17 years with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1, 2020–April 24, 2021. MMWR 2021 Jun 4:70

Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA (Research letter) 2021 (published online Apr 7)

Hawrilenko M, Kroshus E, Tandon P, et al. The association between school closures and child mental health during COVID-19. JAMA Netw Open 2021 Sep 3;4(9):e2124092

Heesakkers H, Hoeven JGVD, Corsten S, et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA 2022 (published online Jan 24)

Heftdal LD, Schultz M, Lange T, et al. Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: real life data from the Capital Region of Denmark. Clin Infect Dis 2022 (published Jan 7)

Her AY, Bhak Y, Jun EJ, et al. Sex-specific difference of in-hospital mortality from COVID-19 in South Korea. PLOS One 2022 (published online Jan 24)

Hernandez-Romieu AC, Leung S, Mbanya A, et al. Health care utilization and clinical characteristics of nonhospitalized adults in an integrated health care system 28-180 says after COVID-19 diagnosis—Georgia, May 2020–March 2021. MMWR 2021 Apr 23;70

Hillis SD, Blenkinsop A, Villaveces A, et al. COVID-19-associated orphanhood and caregiver death in the United States. Pediatrics 2021 (published online Oct 1)

Hirschtick JL, Titus AR, Slocum E, et al. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin Infect Dis 2021 (published online May 19)

Hodges E, Lefferts B, Bates E, et al. Use of rapid antigen testing for SARS-CoV-2 in remote communities—Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021. MMWR Morb Mortal Wkly Rep 2021 (published online Aug 19)

Hoebel J, Michalski N, Diercke M, et al. Emerging socioeconomic disparities in COVID-19–related deaths during the second pandemic wave in Germany. Int J Infect Dis 2021 (published online Oct 28)

Hollis ND, Li W, Van Dyke ME, et al. Racial and ethnic disparities in incidence of SARS-CoV-2 infection, 22 US states and DC, January 1–October 1, 2020. Emerg Infect Dis (Dispatch) 2021 May;27(5)

Honein MA, Barrios LC, Brooks JT. Data and policy to guide opening schools safely to limit the spread of SARS-CoV-2 infection. JAMA (Viewpoint) 2021 (published online Jan 26)

Horby PW, Estcourt L, Peto L, etal, for the RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet 2021 (published online May 14)

Horwitz LI, Garry K, Prete AM, et al. Six-month outcomes in patients hospitalized with severe COVID-19. J Gen Intern Med 2021 (published online Aug 5)

Hossain M, Faisal NH. Modeling aerosol cloud aerodynamics during human coughing, talking, and breathing actions. AIP Adv 2021 Apr 6;11(4)

Hotez PJ. Anti-science kills: from Soviet embrace of pseudoscience to accelerated attacks on US biomedicine. PLoS Biol 2021 (published online Jan 28)

Hou C, Hu Y, Yang H, et al. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank. BMC Med 2021 Nov 16;19(301)

Hozayen SM, Zychowski D, Benson S, et al. Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients. EClinicalMedicine 2021 (published online Sep 24)

Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021 (published online Aug 27)

Hughes MM, Wang A, Grossman MK, et al. County-level COVID-19 vaccination coverage and social vulnerability—United States, December 14, 2020–March 1, 2021. MMWR 2021 Mar 17;70

Huls A, Costa AC, Dierssen M, et al. Medical vulnerability of individuals with Down syndrome to severe COVID-19: data from the trisomy 21 research society and the UK ISARIC4C survey. EClinicalMedicine 2021 (published online Feb 22)

Humble RM, Sell H, Dube E, et al. Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: results from a cross-sectional national survey. Vaccine 2021 (published online Oct 8)

IHME. Estimation of total mortality due to COVID-19. Seattle, WA: Institute for Health Metrics and Evaluation (IHME), May 6, 2021

Inzaule SC, Ondoa P, Loembe MM, et al. COVID-19 and indirect health implications in Africa: impact, mitigation measures, and lessons learned for improved disease control. PLOS Med 2021 (published online Jun 23)

Ioannou GN, Green P, Fan VS, et al. Development of COVIDVax model to estimate the risk of SARS-CoV-2–related death among 7.6 million US veterans for use in vaccination prioritization. JAMA Netw Open 2021 (published online Apr 6)

Irons NJ, Raftery AE. Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys. Proc Natl Acad Sci 2021 Aug 3;118(31):e2103272118

Islam MS, Kamal AH, Kabir A, et al. COVID-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence. PLOS One 2021 (published online May 12)

Islam N, Shkolnikov VM, Acosta R, et al. Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ 2021 May 19;373:n1137

Ito K, Piantham C, Nishiura H. Predicted dominance of variant delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021. Eurosurveill (Rapid communication) 2021 Jul 8;26(27)

Jabagi MJ, Botton J, Bertrand M, et al. Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in people aged 75 years or older. JAMA 2021 (published online Nov 22)

Jabal KA, Ben-Amran H, Beiruti K, et al. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Eurosurveill 2021 Feb 11;26(6)

Jacob JT, Baker JM, Fridkin SK, et al. Risk factors associated with SARS-CoV-2 seropositivity among US health care personnel. JAMA Netw Open 2021 Mar 10;4(3):e211283

Jacobs JL, Bain W, Naqvi A, et al. SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes. Clin Infect Dis 2021 (published online Aug 10)

Jain SS, Steele JM, Fonseca B, et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics 2021 (published online Oct 15)

Jefferson T, Spencer EA, Brassey J, et al. Transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals. A systematic review. Clin Microbiol Infect 2021 (published online Oct 29)

Jeong M, Ocwieja KE, Han D, et al. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med 2021 Oct 29;1(44)

Jiang L, Liu Y, Su W, et al. Decreased dengue cases attributable to the effect of COVID-19 in Guangzhou in 2020. PLOS Negl Trop Dis 2021 (published online May 26)

Jimenez ME, Rivera-Nunez Z, Crabtree BF, et al. Black and Latinx community perspectives on COVID-19 mitigation behaviors, testing, and vaccines. JAMA Netw Open 2021 Jul 15; 4(7):e2117074

Jin M, Lu Z, Zhang X, et al. Clinical characteristics and risk factors of fatal patients with COVID-19: a retrospective cohort study in Wuhan, China. BMC Infect Dis 2021 Sep 14;21(951)

Joshi S, Smith Z, Soman S, et al. Low versus high dose methylprednisolone in adult patients with COVID-19: less is more. Open Forum Infect Dis 2021 (published online Dec 8)

Joubert A, Andry F, Bertolotti A, et al. Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: a cohort study in a SARS-CoV-2 testing center on Reunion island. PLOS Negl Trop Dis 2021 (published online Apr 26)

Joy G, Artico J, Kurdi H, et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC 2021 (published online May 8)

Juhwan Oh, Lee HY, Khuong QL, et al. Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries. Sci Rep 2021 (published online Jul 2)

Juul S, Nielsen EE, Feinberg J, et al. Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS One 2021 (published online Mar 11)

Kadri SS, Sun J, Lawandi A, et al. Association between caseload surge and COVID-19 survival in 558 U.S. hospitals, March to August 2020. Ann Intern Med 2021 (published online Jul 6)

Kalil AC, Mehta AK, Patterson TF, et al. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med 2021 (published online Oct 18)

Kalish H, Klumpp-Thomas C, Hunsberger S, et al. Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med 2021 Jul 7;13(601)

Kalkowska DA, Voorman A, Pallansch MA, et al. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication. Vaccine 2021 (published online Apr 27)

Kamar N, Abravanel F, Marion O, et al. Assessment of 4 doses of SARS-CoV-2 messenger RNA–based vaccine in recipients of a solid organ transplant. JAMA Netw Open 2021 Nov 24;4(11):e2136030. 

Kandula S, Shaman J. Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: a modeling study. PLOS Med 2021 (published online Jul 13)

Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci 2021 Mar 9;118(10):e2021726118

Karikalan M, Chander V, Mahajan S, et al. Natural infection of Delta mutant of SARS-CoV-2 in Asiatic Lions of India. Transbound Emerg Dis 2021 (published online Aug 17)

Karmakar M, Lantz PM, Tipirneni R. Association of social and demographic factors with COVID-19 incidence and death rates in the US. JAMA Netw Open 2021 Jan 29;4(1):e2036462

Katikireddi SV, Cerqueira-Silva T, Vasileiou E, et al. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet 2021 (published online Dec 20)

Kelly G, Petti S, and Noah N. COVID-19, non-COVID-19 and excess mortality rates not comparable across countries. Epidemiol Infect 2021 (published online Aug 2)

Kessel C, Vollenberg R, Masjosthusmann K, et al. Discrimination of COVID‐19 from inflammation‐induced cytokine storm syndromes by disease‐related blood biomarkers. Arthritis Rheumatol (Brief report) 2021 (published online Apr 20)

Khairat S, Zou B, Adler-Milstein J. Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US. Am J Infect Control 2022 (published online Jan 4)

Kidd M, Richter A, Best A, et al. S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-qPCR. J Infect Dis 2021 (published online Feb 13)

Kim C, McGee S, Khuntia S, et al. Characteristics of COVID-19 cases and outbreaks at child care facilities—District of Columbia, July-December 2020. MMWR 2021 May 21;70(20):744-8

Kim HW, Jenista ER, Wendell DC, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol 2021 (published online Jun 29)

Kim J, Jung J, Kim TH, et al. Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study. BMC Infect Dis 2021 Sep 14;21(952)

Kim P, Gordon SM, Sheehan MM, et al. Duration of SARS-CoV-2 natural immunity and protection against the delta variant: a retrospective cohort study. Clin Infect Dis 2021 (published online Dec 3)

Kim S, Capasso A, Cook SH, et al. Impact of COVID-19-related knowledge on protective behaviors: the moderating role of primary sources of information.  PLOS One 2021 (published online Nov 29)

Konig M, Torgauten HM, Tran TT, et al. Immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis and weak immune response after COVID-19 vaccination. JAMA Neurol 2022 (published online Jan 24)

Kowall B, Standl F, Oesterling F, et al. Excess mortality due to COVID-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden, and Spain. PLOS One 2021 (published online Aug 3)

Koyama AK, Koumans EH, Sircar K, et al. Severe outcomes, readmission, and length of stay among COVID-19 patients with intellectual and developmental disabilities. Int J Infect Dis 2022 (published online Jan 22)

Kraay AN, Hayashi MA, Berendes DM, et al. Risk for fomite-mediated transmission of SARS-CoV-2 in child daycares, schools, nursing homes, and offices. Emerg Infect Dis 2021 Apr;27(4)

Kraemer MU, Hill V, Ruis C, et al. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science 2021 (published online Jul 22)

Krammer F, Srivastava K, Alshammary H, et al. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med (Letter) 2021 (published online Mar 10)

Krantz MS, Swah JH, Stone CA Jr, et al. Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose. JAMA Intern Med (Research letter) 2021 (published online Jul 26)

Good N, Fedak KM, Goble D, et al. Respiratory aerosol emissions from vocalization: age and sex differences are explained by volume and exhaled CO2. Environ Sci Technol Lett 2021 (published online Nov 9)

Kristensen JH, Hasselbalch RB, Pries-Heje M, et al. Effect of influenza vaccination on risk of COVID-19–a prospective cohort study of 46,000 health care workers. J Infect Dis 2022 (published online Jan 5)

Kufa T, Jassat W, Cohen C, et al. Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa. Influenza Other Respir Viruses 2021 (published online Nov 18)

Kujawski SA, Yao L, Wang E, et al. Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: a database analysis. Vaccine 2022 (published online Jan 2)

Kumar PN, Hernandez-Sanchez J, Nagel S, et al. Safety and efficacy of tocilizumab 4 or 8 mg/kg in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomized clinical trial. Open Forum Infect Dis 2021 (published online Dec 4)

Kuno T, Miyamoto Y, Iwagami M, et al. The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids. J Antimicrob Chemother 2021 (published online Aug 9)

Lam-Hine T, McCurdy SA, Santora L, et al. Outbreak associated with SARS-CoV-2 B.1.617.2 (delta) variant in an elementary school—Marin County, California, May–June 2021. MMWR Morb Mortal Wkly Rep 2021 Sep 2;70:1214–9

Lambrecq V, HaninA, Munoz-Musat E, et al. Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19. JAMA Netw Open 2021 Mar 15;4(3):e211489

Landacki FR, Teran RA, Gretsch S, et al. COVID-19 outbreak among attendees of an exercise facility—Chicago, Illinois, August-September 2020. MMWR Feb 24; 70

Lau YC, Tsang TK, Kennedy-Shaffer L, et al. Joint estimation of generation time and incubation period for coronavirus disease (COVID-19). J Infect Dis 2021 (published online Aug 23)

Law AC, Peterson D, Walkey AJ, et al. Lottery-based incentives and COVID-19 vaccination rates in the US. JAMA Intern Med 2022 (published online Jan 4)

Lazarus R, Baos S, Cappel-Porter H, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet 2021 (published online Nov 11)

Lebreton G, Schmidt M, Ponnaiah M, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study. Lancet Respir Med 2021 (published online Apr 19)

Lee FC, Adams L, Graves SJ, et al. Counties with high COVID-19 incidence and relatively large racial and ethnic minority populations—United States, April 1–December 22, 2020. MMWR 2021 Mar 24;70

Lee JT, Althomsons SP, Wu H, et al. Disparities in COVID-19 vaccination coverage among health care personnel working in long-term care facilities, by job category, National Healthcare Safety Network—US, Mar 2021. MMWR 2021 Jul 30;70(30):1036-9

Leon TM, Vargo J, Pan ES, et al. Nonpharmaceutical interventions remain essential to reducing COVID-19 burden even in a well-vaccinated society: a modeling study. Open Forum Infect Dis 2021 (published online Aug 9)

Leong A, Cole JB, Brenner LN, et al. Cardiometabolic risk factors for COVID-19 susceptibility and severity: a Mendelian randomization analysis. PLoS Med 2021 (published online Mar 4)

Letizia AG, Ge Y, Vangeti S, et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med 2021 (published online Apr 15)

Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N Engl J Med 2021 (published online Oct 6)

Lewis NM, Hershow RB, Chu VT, et al. Factors associated with participation in elementary school–based SARS-CoV-2 testing—Salt Lake County, Utah, December 2020–January 2021. MMWR 2021 Apr 7;70

Lewis NM, Salmanson AP, Price A, et al. Community-associated outbreak of COVID-19 in a correctional facility—Utah, September 2020–January 2021. MMWR 2021 Apr 2;70(13):467-72

Li J, Hou L, Guo X, et al. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nat Med 2022 (published online Jan 27)

Li L, Robinson LB, Patel R, et al. Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination. JAMA Netw Open 2021 Oct 26;4(10):e2131034

Li P, Zhao W, Kaatz S, et al. Factors associated with risk of postdischarge thrombosis in patients with COVID-19. JAMA Netw Open 2021 Nov 22;4(11):e2135397

Li X, Chan JMC, Lam B, et al. COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities. Clin Infect Dis 2021 (published online Jan 4)

Li-Yan C, Wen-Wen C, Zhi-Wei M, et al. Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis. Int J Infect Dis 2021 (published online Aug 18)

Linsenmeyer K, Charness ME, O'Brien WJ, et al. Vaccination status and the detection of SARS-CoV-2 infection in health care personnel under surveillance in long-term residential facilities. JAMA Netw Open 2021 Nov 10;4(11):e2134229

Liu C, Ginn HM, Dejnirattisal W, et al. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell 2021 (published online Jun 16)

Liu H, He S, Shen L, et al. Simulation-based study of COVID-19 outbreak associated with air-conditioning in a restaurant. Phys Fluids 2021 Feb 9;33(2)

Liu J, Liu Y, Xia H, et al. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature 2021 (published online Jun 10)

Liu P, Xu M, Cao L, et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol J 2021 Aug 3;18(159)

Liu Y, Liu J, Xia H, et al. BNT162b2-elicited neutralization against new SARS-CoV-2 spike variants. N Engl J Med (Correspondence) 2021 (published online May 12)

Liu Y, Liu J, Zia H, et al. Neutralizing activity of BNT162b2-elicited serum—preliminary report. N Engl J Med (Letter) 2021 (published online Feb 17)

Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open (Research letter) 2021 Feb 19;4(2):3210830

Lokken EM, Huebner EM, Taylor GG, et al. Disease severity, pregnancy outcomes and maternal deaths among pregnant patients with SARS-CoV-2 infection in Washington State. Am J Obstet Gynecol 2021 (published online Jan 26)

Lokken EM, Taylor GG, Huebner EM, et al. Higher SARS-CoV-2 infection rate in pregnant patients. Am J Obstet Gynecol 2021 (published online Feb 16)

Long H, Zhao J, Zeng HL, et al. Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. BMC Infect Dis 2021 Dec 27;21(1282)

Longmore DK, Miller JE, Bekkering S, et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care 2021 Apr;44(4)

Lopes MI, Bonjorno LP, Giannini MC, et al. Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 2021 (published online Feb 4)

Lucas C, Klein J, Sundaram ME, et al. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med 2021 (published online May 5)

Luczkowiak J, Laboid N, Rivas G, et al. Neutralizing response against SARS-CoV-2 variants 8 months after BNT162b2 vaccination in naive and COVID-19 convalescent individuals. J Infect Dis 2021 (published online Dec 28)

Luo C, Yang Y, Liu Y, et al. Intention to COVID-19 vaccination and associated factors among health care workers: a systematic review and meta-analysis of cross-sectional studies. Am J Infect Control 2021 (published online Jul 14)

Luo L, Luo T, Du M, et al. Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Infect 2021 (published online Nov 19)

Lythgoe KA, Hall M, Ferretti L, et al. SARS-CoV-2 within-host diversity and transmission. Science 2021 (published online Mar 9)

Lythgoe MP, Middleton P. Comparison of COVID-19 vaccine approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada. JAMA Netw Open (Research letter) 2021 (published online Jun 25)

Macchia A, Ferrante D, Angeleri P, et al. Evaluation of a COVID-19 vaccine campaign and SARS-CoV-2 infection and mortality among adults aged 60 years and older in a middle-income country. JAMA Netw Open 2021 Oct 29;4(10):e2130800

MacLean OA, Lytras S, Weaver S, et al. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen. PLoS Biol 2021 (published online Mar 12)

MacNeil JR, Su JR, Broder KR, et al. Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients—United States, April 2021. MMWR 2021 (published online Apr 27)

Madera S, Crawford E, Langelier C, et al. Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults. Sci Rep 2021 Feb 4;11:3044

Madewell ZJ, Yang Y, Longini IM, et al. Factors associated with household transmission of SARS-CoV-2: an updated systematic review and meta-analysis. JAMA Netw Open 2021;4(8):e2122240

Magesh S, John D, Li WT, et al. Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic-review and meta-analysis. JAMA Netw Open 2021 Nov 11;4(11):e2134147

Maher MC, Bartha I, Weaver S, et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci Transl Med 2022 (published online Jan 11)

Mallach G, Kasloff SB, Kovesi T, et al. Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic. PLOS One 2021 (published online Sep 30)

Mallajosyula V, Ganjavi C, Chakraborty S, et al. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Sci Immunol 2021 Jul 1;6(61):eabg5669

Manisty C, Otter AD, Treibel TA, et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet 2021 (published online Feb 25)

Mant M, Aslemand A, Prine A, et al. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: a multi-methods study. PLOS One 2021 (published online Aug 3)

Marquez N, Ward JA, Parish K, et al. COVID-19 incidence and mortality in federal and state prisons compared with the US population, April 5, 2020, to April 3, 2021. JAMA Netw Open 2021 (published online Oct 6)

Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England. Lancet 2021 (published online Apr 30)

Matta J, Wiernik E, Robineau O, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med 2021 (published online Nov 8)

Matthias J, Patrick S, Wiringa A, et al. Epidemiologically linked COVID-19 outbreaks at a youth camp and men’s conference—Illinois, June–July 2021. MMWR Morb Mortal Wkly Rep 2021 (published online Aug 31)

Maves RC, Richard SA, Lindholm DA, et al. Predictive value of an age-based modification of the national early warning system in hospitalized patients with COVID-19. Open Forum Infect Dis 2021 (published online Aug 10)

Mazeraud A, Jamme M, Mancusi RL, et al. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 2021 (published online Nov 11)

McCallum M, Bassi J, De Marco A, et al. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science 2021 (published online Jul 1)

McCormick DW, Richardson LC, Young PR, et al. Deaths in children and adolescents associated with COVID-19 and MIS-C in the United States. Pediatrics 2021 (published online Oct 22)

McDuie F, Matchett E, Prosser DJ, et al. Pathways for avian influenza virus spread: GPS reveals wild waterfowl in commercial livestock facilities and connectivity with the natural wetland landscape. Transbound Emerg Dis 2022 (published online Jan 2)

McNeil CM, Flores AR, Kaplan SL, et al. The indirect impact of the SARS-CoV-2 pandemic on invasive Group A Streptococcus, Streptococcus pneumoniae and Staphylococcus aureus infections in Houston Area children. Pediatr Infect Dis J 2021 Aug;40(8):e313-6

Meister TL, Fortmann J, Todt D, et al. Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351. J Infect Dis 2021 (published online May 16)

Memel ZN, Lee JJ, Foulkes AS, et al. Association of statins and 28-day mortality in patients hospitalized with SARS CoV-2 infection. J Infect Dis 2021 (published online Oct 19)

Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect 2021 (published online Jun 20)

Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 2021 (published online Apr 27)

Mensah AA, Lacy J, Stowe J, et al. Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study. J Infect 2022 (published online Jan 24)

Meyer MN, Gjorgjieve T, Rosica D. Trends in health care worker intentions to receive a COVID-19 vaccine and reasons for hesitancy. JAMA Netw Open 2021 (published online Mar 23)

Miller E, Waight PA, Andrews NJ, et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England. J Infect 2021 (published online Aug 2)

Miller MJ, Xu L, Qin J, et al. Impact of COVID-19 on cervical cancer screening rates among women aged 21-65 years in a large integrated health care system—southern California, January 1 September 30, 2019, and January 1 September 30, 2020. MMWR 2021 Jan 29;70(4)109-13

Milman O, Yelin I, Aharony N, et al. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals. Nat Med 2021 (published online Jun 10)

Mishra A, Kumar N, Bhatia S, et al. SARS-CoV-2 Delta variant among Asiatic lions, India. Emerg Infect Dis 2021 (published online Aug 30)

Moghadas SM, Vilches TN, Zhang K, et al. Evaluation of COVID-19 vaccination strategies with a delayed second dose. PLOS Biol 2021 (published online Apr 21)

Moller IJB, Utke AR, Rysgaard UK, et al. Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen detecting tests performed at home. Int J Infect Dis 2022 (published online Jan 14)

Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 2021 (published online Aug 3)

Momplaisir FM, Kuter BJ, Ghadimi F, et al. Racial/ethnic differences in COVID-19 vaccine hesitancy among health care workers in 2 large academic hospitals. JAMA Netw Open 2021 (published online Aug 30)

Monod M, Blenkinsop A, Xi X, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science 2021 Mar 26;371(6536):eabe8372

Monod M, Blenkinsop A, Xiaoyue X, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science 2021 (published online Feb 2)

Montgomery J, Ryan M, Engler R, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol (Brief report) 2021 (published online Jun 29)

Moore JP, Offit PA. SARS-CoV-2 vaccines and the growing threat of viral variants. JAMA (Viewpoint) 2021 (published online Jan 28)

Morawska L, Allen J, Bahnfleth W, et al. A paradigm shift to combat indoor respiratory infection. Science (Policy forum) 2021 May 14;372(6543):689-91

Morris AC, Sharrocks K, Bousfield R, et al. The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units. Clin Infect Dis 2021 (published online Oct 30)

Moshkovits I, Shepshelovich D, et al. Emergency use authorizations of COVID-19–related medical products. JAMA Intern Med 2021 (published online Dec 20)

Motta FC, McGoff KA, Deckard A, et al. Assessment of simulated surveillance testing and quarantine in a SARS-CoV-2–vaccinated population of students on a university campus. JAMA Health Forum 2021 Oct 1;2(10):e213035

Mozaffari E, Chandak A, Zhang Z, et al. Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort. Clin Infect Dis 2021 (published online Oct 1)

Muik A, Wallisch AK, Sanger B, et al. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera. Science 2021 (published online Jan 29)

Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol 2021 (published online Aug 26)

Muller NF, Wagner C, Frazar CD, et al. Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State. Sci Transl Med 2021 (published online May 3)

Munday JD, Jarvis CI, Gimma A, et al. Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data. BMC Med 2021 (published online Sep 10)

Munitz A, Yechezkel M, Dickstein Y, et al. BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high risk populations in Israel. Cell Rep Med 2021 (published online Apr 18)

Munoz-Price LS, Rivera F, Ledeboer N. Air contamination of households versus hospital inpatient rooms occupied by SARS-CoV-2 positive patients. Infect Control Hosp Epidemiol 2021 (published online Feb 4)

Murthy BP, Sterrett N, Weller D, et al. Disparities in COVID-19 vaccination coverage between urban and rural counties—United States, December 14, 2020–April 10, 2021. MMWR 2021 18 May;70

Murthy BP, Zell E, Kirtland K, et al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations—10 U.S. jurisdictions, March–September 2020. MMWR 2021 Jun 11;70(23):840-5

Mwananyanda L, Gill CJ, MacLeod W, et al. Covid-19 deaths in Africa: prospective systematic postmortem surveillance study. BMJ 2021 Feb 17;372:n334

Nadeau SA, Vaughan TG, Scire J, et al. The origin and early spread of SARS-CoV-2 in Europe. Proc Natl Aca Sci 2021 2021 Mar 2;118(9):e2012008118

Naesens R, Mertes H, Clukers J, et al. SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital. Epidemiol Infect 2021 (published online Aug 10)

Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021 (published online Mar 22)

Naleway AL, Grant L, Caban-Martinez AJ, et al. Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: eight US locations, January–September 2021. Influenza Respir Viruses 2022 (published online Jan 13)

Narayan P, Kumar S, Mohan M, et al. Uptake and impact of vaccination against COVID-19 among healthcare workers-evidence from a multicentre study. Am J Infect Control 2021 (published online Nov 11)

Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021 (published online May 26)

Nau C, Bruxvoort K, Navarro RA, et al. COVID-19 inequities across multiple racial and ethnic groups: results from an integrated health care organization. Ann Intern Med (Letter) 2021 (published online Apr 20)

Navar AM, Purinton SN, Hou Q, et al. The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19. PLOS One 2021 (published online Jul 21)

Navaratnam AV, Gray WK, Day J, et al. Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data. Lancet Respir Med 2021 (published online Feb 15)

Nehme M, Braillard O, Chappuis F, et al. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 2021 (published online Jul 6)

Nerhood KJ, James ER, Hardin A, et al. Screening programs for SARS-CoV-2 infections on a university campus—Austin, Texas, September 30–November 30, 2020. MMWR Morb Mortal Wkly Rep 2021 Sep 2;70:1201-5

Ngiam JN, Chew NWS, Tham SM, et al. Utility of conventional clinical risk scores in a low-risk COVID-19 cohort. BMC Infect Dis 2021 Oct 24;21(1094)

Nguyen KH, Anneser E, Toppo A, et al. Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States. Vaccine 2021 (published online Nov 18)

Nguyen KH, Nguyen K, Geddes M, et al. Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April—August, 2021. Am J Infect Control 2021 (published online Dec 28)

Nguyen KH, Srivastav A, Razzaghi H, et al. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination—United States, September and December 2020. MMWR 2021 (published online Feb 9)

Nguyen KH, Yankey D, Coy KC, et al. COVID-19 vaccination coverage, intent, knowledge, attitudes, and beliefs among essential workers, United States. Emerg Infect Dis 2021 (published online Sep 22)

Nichter B, Hill ML, Na PJ, et al. Prevalence and trends in suicidal behavior among US Military veterans during the COVID-19 pandemic. JAMA Psychiatry 2021 (published online Aug 25)

Niemi ME, Karjalainen J, Liao RG, et al, for the COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 2021 (published online Jul 8)

Noh J, Danuser G. Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide. PLoS One 2021 (published onoline Feb 8)

Nuno M, Garcia Y, Rajasekar G, et al. COVID-19 hospitalizations in five California hospitals: a retrospective cohort study. BMC Infect Dis 2021 (published online Sep 10)

Nyberg T, Twohig KA, Harris RJ, et al. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis. BMJ 2021 (published online Jun 15)

O'Brien MP, Forleo-Neto E, Musser BJ, et al. Subcutaneous REGEN-COV antibody combination to prevent COVID-19. N Engl J Med 2021 (published online Aug 4)

O'Hearn M, Liu J, Cudhea F, et al. Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis. J Am Heart Assoc 2021 (published online Feb 25)

O'Keefe JB, Minton HC, Morrow M, et al. Post-acute sequelae of SARS-CoV-2 infection and impact on quality of life 1-6 months after illness and association with initial symptom severity. Open Forum Infect Dis 2021 (published online Jul 27)

Oi I, Ito I, Hirabayashi M, et al. Pneumonia caused by severe acute respiratory syndrome coronavirus 2 and influenza virus: a multicenter comparative study. Open Forum Infect Dis 2021 (published online May 29)

Olender SA, Walunas TI, Martinez E, et al. Remdesivir versus standard-of-care for severe coronavirus disease 2019 infection: an analysis of 28-day mortality. Open Forum Infect Dis 2021 (published online May 26)

Oliver SE, Gargano JW, Scobie H, et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Janssen COVID-19 vaccine—United States, February 2021. MMWR Mar 2;70

Oliver SE, Retchless AC, Blain AE, et al. Risk factors for invasive meningococcal disease belonging to a novel urethritis clade of Neisseria meningitidis — United States, 2013–2017. Open Forum Infect Dis 2022 (published online Jan 25)

Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020-2021. MMWR 2021 Jul 23;70(29):1013-9

Olson SM, Newhams MM, Halasa NB, et al. Effectiveness of BNT162b2 vaccine against critical COVID-19 in adolescents. N Engl J Med 2022 (published online Jan 12)

Olson SM, Newhams MM, Halasa NB, et al. Effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12–18 years — United States, June–September 2021. MMWR Morb Mortal Wkly Rep 2021 (published online Oct 19)

Ortega N, Ribes M, Vidal M, et al. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses. Nat Commun 2021 Aug 6;12(4740)

Osei SA, Biney RP, Anning AS, et al. Low incidence of COVID-19 case severity and mortality in Africa; could malaria co-infection provide the missing link? BMC Infect Dis 2022 Jan 22;22(78)

Oskotsky T, Maric I, Tang A, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open 2021 Nov 15;4(11):e2133090

Oster E, Jack R, Halloran C, et al. Disparities in learning mode access among K–12 students during the COVID-19 pandemic, by race/ethnicity, geography, and grade level—United States, September 2020–April 2021. MMWR 2021 29 Jun;70

Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA Netw Open 2022 (published online Jan 25)

Ostergaard SD, Schmidt M, Horvath-Puho E, et al. Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence? Lancet 2021 (published online Mar 30)

Ouldali N, Toubiana J, Antona D, et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 2021 (published online Feb 1)

Padamsee TJ, Bond RM, Dixon GN, et al. Changes in COVID-19 vaccine hesitancy among Black and white individuals in the US. JAMA Netw Open 2022 Jan 21;5(1):e2144470

Painter EM, Ussery EN, Patel A, et al. Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program—United States, December 14, 2020–January 14, 2021. MMWR 2021 (published online Feb 1)

Pang JK, Jones SP, Waite LL, et al. Probability and estimated risk of SARS-CoV-2 transmission in the air travel system. Travel Med Infect Dis 2021 (published online Jun 26)

Parhizkar H, Dietz L, Olsen-Martinez A, et al. Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19. Clin Infect Dis 2022 (published online Jan 6)

Paris C, Perrin S, Hamonic S, et al. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data. Clin Microbiol Infect 2021 (published online Jul 12)

Paris C, Tadie E, Heslan C, et al. Risk factors for SARS-CoV-2 infection among health care workers. Am J Infect Control 2021 (published online Nov 11)

Parker JJ, Octaria R, Smith MD, et al. Characteristics, comorbidities, and data gaps for coronavirus disease deaths, Tennessee, USA. Emerg Infect Dis 2021 (published online Aug 23)

Patalon T, Gazit S, Pitzer VE, et al. Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine. JAMA Intern Med 2021 (published online Nov 30)

Patanavanich R, Glantz SA. Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis. BMC Public Health 2021 (published online Aug 16)

Patone M, Thomas K, Hatch R, et al. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study. Lancet Infect Dis 2021 (published online Jun 22)

Paul P, France AM, Aoki Y, et al. Genomic surveillance for SARS-CoV-2 variants circulating in the United States, December 2020–May 2021. MMWR 2021 Jun 11;70(23):846-50

Perl SH, Uzan-Yuzari A, Klainer H, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA (Research letter) 2021 (published online Apr 12)

Perlis RH, Ognyanova K, Santillana M, et al. Association of major depressive symptoms with endorsement of COVID-19 vaccine misinformation among US adults. JAMA Netw Open 2022 Jan 21;5(1):e2145697

Petty LA, Flanders SA, Vaughn VM, et al. Risk factors and outcomes associated with community-onset and hospital-acquired co-infection in patients hospitalized for COVID-19: a multi-hospital cohort study. Infect Control Hosp Epidemiol 2021 (published online Jul 26)

Pickard A, Calverley BC, Chang J, et al. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells. PLOS Pathog 2021 (published online Sep 9)

Pink SL, Chu J, Druckman JN, et al. Elite party cues increase vaccination intentions among Republicans. Proc Natl Acad Sci (Brief report) 2021 Aug 10;118(32):e2106559118

Pottegard A, Lund LC, Karlstad O, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021 May 5;373:n1114

Poudel AK, Zhu S, Cooper N, et al. Impact of COVID-19 on health-related quality of life of patients: a structured review. PLOS One 2021 (published online Oct 28)

Prendecki M, Clarke C, Brown J, et al. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet 2021 (published online Feb 25)

Preston LE, Chevinsky JR, Kompaniyets L, et al. Characteristics and disease severity of US children and adolescents diagnosed with COVID-19. JAMA Netw Open (Research letter) 2021 Apr 9;4(4):e215298

Pritchard E, Matthews PC, Stoesser N, et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med 2021 (published online Jun 9)

Qianhui Wu, Dudley MZ, Chen X, et al. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med 2021 Jul 28;19(173)

Quintana-Domeque C, Lee I, Zhang A, et al. Anxiety and depression among medical doctors in Catalonia, Italy, and the UK during the COVID-19 pandemic. PLOS One 2021 (published online Nov 2)

Rabalski L, Kosinski M, Smura T, et al. Severe acute respiratory syndrome coronavirus 2 in farmed mink (Neovision vision), Poland. Emerg Infect Dis 2021 (published online Aug 9)

Radin JM, Quer G, Ramos E, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open (Research letter) 2021 Jul 7;4(7):e2115959

Raghav K, Anand S, Gothwal A, et al. Underreporting of race/ethnicity in COVID-19 research. Int J Infect Dis (Short communication) 2021 (published online Jun 1)

Rahi M, Le Pluart D, Beaudet A, et al. Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France. BMC Infect Dis 2021 Aug 13;21(812)

Ram-Mohan N, Kim D, Zudock EJ, et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin Infect Dis 2021 (published online May 5)

Ramachandran R, Ross JS, Miller JE, et al. Access to COVID-19 vaccines in high-, middle-, and low-income countries hosting clinical trials. JAMA Netw Open 2021 Nov 18;4(11):e2134233

Ramani SL, Samet J, Franz CK, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol 2021 (published onlkine Feb 18)

Rauch JN, Valois E, Ponce-Rojas JC, et al. Comparison of severe acute respiratory syndrome coronavirus 2 screening using reverse transcriptase–quantitative polymerase chain reaction or CRISPR-based assays in asymptomatic college students. JAMA Netw Open 2021 (published online Feb 11)

Razai MS, Oakeshott P, Esmail A, et al. COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors. J Royal Soc Med 2021 (published online Jun 2)

Rebmann T, Alvino RT, Holdsworth JE. Availability and crisis standards of care for personal protective equipment during fall 2020 of the COVID-19 pandemic: a national study by the APIC COVID-19 Task Force. Am J Infect Control 2021 (published online Mar 25)

RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021 (published online Nov 17)

RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med 2021 (published online Oct 18)

Redmond SN, Jones LD, Sadri N, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated and unvaccinated healthcare personnel in a Veterans Affairs healthcare system. Infect Control Hosp Epidemiol 2021 (published online May 27)

Reindl-Schwaighofer R, Heinzel A, Marydorfer M, et al. Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients. JAMA Intern Med 2021 (published online Dec 20)

Reisch T, Heiler G, Hurt J, et al. Behavioral gender differences are reinforced during the COVID-19 crisis. Sci Rep 2021 Sep 28;11(19241)

REMAP-CAP Investigators. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med 2021 (published online Feb 25)

Renaud M, Thibault C, Le Normand F, et al. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw Open (Research letter) 2021 Jun 24;4(6):e2115352

Rentsch CT, Beckman JA, Tomlinson L, et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 2021 Feb 11;372:n311

Reses HE, Jones ES, Richardson DB, et al. COVID-19 vaccination coverage among hospital-based healthcare personnel reported through the Department of Health and Human Services Unified Hospital Data Surveillance System, United States, January 20, 2021-September 15, 2021. Am J Infect Control 2021 (published online Nov 17)

Reynolds CJ, Pade C, Gibbons JM, et al. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science 2021 (published online Apr 30)

Riley S, Wang H, Eales O, et al. REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant. Imperial College London (Preprint—working paper) 2021 Jun 17

Prattes J, Wauters J, Giacobbe DR, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients–a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021 (published online Aug 25)

Rivelli A, Fitzpatrick V, Blair C, et al. Incidence of COVID-19 reinfection among Midwestern healthcare employees. PLOS One 2021 (published online Jan 4)

Roberts DL, Rossman J, Jaric I. Dating first cases of COVID-19. PLOS Pathog 2021 (published online Jun 24)

Robertson CT, Bentele K, Meyerson B, et al. Effects of political versus expert messaging on vaccination intentions of Trump voters. PLOS One 2021 (published online Sep 27)

Rogers-Brown JS, Wanga V, Okoro C, et al. Outcomes among patients referred to outpatient rehabilitation clinics after COVID-19 diagnosis—US, Jan 2020–Mar 2021. MMWR Jul 9;70(27)

Romano SD, Blackstock AJ, Taylor EV, et al. Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region—United States, March–December 2020. MMWR 2021 Apr 12:70

Rosenberg ES, Dorabawila V, Easton D, et al. COVID-19 vaccine effectiveness in New York State. N Engl J Med 2021 (published online Dec 1)

Rosenberg ES, Holtgrave DR, Dorabawila V, et al. New COVID-19 cases and hospitalizations among adults, by vaccination status—New York, May 3–July 25, 2021. MMWR Morb Mortal Wkly Rep 2021 Aug 26;70(34):1150-5

Rossen LM, Ahmad FB, Anderson RN, et al. Disparities in excess mortality associated with COVID-19—United States, 2020. MMWR Morb Mortal Wkly Rep 2021 (published online Aug 19)

Rossen LM, Branum AM, Ahmad FB, et al. Update on excess deaths associated with the COVID-19 pandemic—United States, January 26, 2020–February 27, 2021. MMWR (Notes from the field) Apr 16;70(15):570-1

Rumke LW, Groenveld FC, van Os YMG, et al. In depth characterization of vaccine breakthrough infections with SARS-CoV-2 among healthcare workers of a Dutch academic medical center. Open Forum Infect Dis 2021 (published online Nov 6)

Rushovich T, Boulicault M, Chen JT, et al. Sex disparities in COVID-19 mortality vary across US racial groups. J Gen Intern Med 2021 (published online Apr 5)

Saadat S, Tehrani ZR, Logue J, et al. Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2. JAMA (Research letter) 2021 (published online Mar 1)

Sabino EC, Buss LF, Carvalho MP, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet (Comment) 2021 (published online Jan 27)

Sacarny A, Daw JR. Inequalities in COVID-19 vaccination rates in the 9 largest US cities. JAMA Health Forum 2021 Sep 3;2021(9):e212415

Sachdev DD, Ng RC, Sankaran M, et al. Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients — San Francisco, California, January 29-July 2, 2021. Clin Infect Dis 2021 (published online Dec 20)

Sadoff J, Davis K, Douoguih M. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination—response from the manufacturer. N Engl J Med (Correspondence) 2021 (published online Apr 16)

Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med 2021 (published online Apr 21)

Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Proc Natl Acad Sci USA 2021 (published online Aug 9)

Sajgalik P, Garzona-Navas A, Csecs I, et al. Characterization of aerosol generation during various intensities of exercise. Chest J 2021 (published online May 3)

Salerno S, Messana JM, Gremel GW, et al. COVID-19 risk factors and mortality outcomes among medicare patients receiving long-term dialysis. JAMA Netw Open 2021 Nov 17;4(11):e2135379

Sallis R, Young DR, Tartof SY, et al. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients. Br J Sports Med 2021 (published online Apr 13)

Samet JM, Burke TA, Lakdawala SS, et al. SARS-CoV-2 indoor air transmission is a threat that can be addressed with science. Proc Natl Acad Sci USA 2021 (published online Nov 2)

Sami S, Turbyfill CR, Daniel-Wayman S, et al. Community transmission of SARS-CoV-2 associated with a local bar opening event—Illinois, February 2021. MMWR Apr 5;70

Sandoval M, Nguyen DT, Vahidy FS, et al. Risk factors for severity of COVID-19 in hospital patients age 18-29 years. PLOS One 2021 (published online Jul 30)

Sanmarchi F, Golinelli D, Lenzi J, et al. Exploring the gap between excess mortality and COVID-19 deaths in 67 countries. JAMA Netw Open (Research letter) 2021 Jul 16;4(7):e2117359

Scherer AM, Gedlinske AM, Parker AM, et al. Acceptability of adolescent COVID-19 vaccination among adolescents and parents of adolescents—US, Apr 15-23, 2021. MMWR 2021 Jul 9;70

Schmidt H, Weintraub R, Williams MA, et al. Equitable allocation of COVID-19 vaccines in the United States. Nat Med 2021 (published online May 18)

Schuit M, Biryukov J, Beck K, et al. The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates. J Infect Dis 2021 (published onoline Apr 2)

Schultz NH, Sorvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med (Brief report) 2021 (published online Apr 9)

Schwarz T, Tober-Lau P, Hillus D, et al. Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany. Emerg Infect Dis 2021 Aug;27(8)

Seessle, J, Waterboer T, Hoppchen T, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021 (published online Jul 5)

Shaefi S, Brenner SK, Gupta S, et al. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med 2021 (published online Feb 2)

Shamout FE, Shen Y, Wu N, et al. An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department. NPJ Digit Med 2021 (published online May 12)

Sharif N, Alzahrani KJ, Ahmed SN, et al. Protective measures are associated with the reduction of transmission of COVID-19 in Bangladesh: a nationwide cross-sectional study. PLOS One 2021 (published online Nov 22)

Shasha D, Bareket R, Sikron FH, et al. Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study. Clin Microbiol Infect 2021 (published online Sep 27)

Shavit R, Maoz-Segal R, Iancovici-Kidon M, et al. Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk. JAMA Netw Open 2021 (published online Aug 31)

Shaw J, Hanley S, Stewart T, et al. Health care personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization. Clin Infect Dis 2021 (published online Sep 1)

Shaw RH, Stuart A, Greenland M, et al. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet 2021 (published online May 12)

Shay DK, Gee J, Su JR, et al. Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR 2021 Apr 30;70

Sheehan MM, Reddy AJ, Rothberg MB. Reinfection rates among patients who previously tested positive for COVID-19: a retrospective cohort study. Clin Infect Dis 2021 (published online Mar 15)

Shelton JF, Shastri AJ, Fletez-Brant K, et al. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet 2022 (published online Jan 17)

Shen K, Loomer L, Abrams H, et al. Estimates of COVID-19 cases and deaths among nursing home residents not reported in federal data. JAMA Netw Open 2021 (published online Sep 9)

Shi L, Tang W, Hu H, et al. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China. BMC Infect Dis 2021 (published online Aug 7)

Shi Q, Wang Z, Liu J, et al. Risk factors for poor prognosis in children and adolescents with COVID-19: a systematic review and meta-analysis. EClinicalMedicine 2021 (published online Oct 18)

Shi T, Pan J, Katikiereddi SV, et al. Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study. Lancet Resp Med 2021 (published online Nov 30)

Shiels MS, Haque AT, Haozous EA, et al. Racial and ethnic disparities in excess deaths during the COVID-19 pandemic, March to December 2020. Ann Intern Med 2021 (published online Oct 5)

Shinde V, Bhikha S, Hoosain Z, et al. Efficacy of NVX-CoV2373 Covid-19 vaccine against the B.1.351 variant. N Engl J Med 2021 (published online May 5)

Sholzberg M, Tang GH, Rahhal H, et al. Heparin for moderately ill patients with Covid-19. medRxiv (Preprint) 2021 (published online Jul 12)

Shriner SA, Ellis JW, Root JJ, et al. SARS-CoV-2 exposure in escaped mink, Utah, USA. Emerg Infect Dis (Research letter) 2021 Mar;27(3)

Shvetsova O, Zhirnov A, Giannelli F, et al. Governor's party, policies, and COVID-19 outcomes: further evidence of an effect. Am J Prev Med 2021 (published online Oct 11)

Silveira MF, Tonial CT, Maranhao AG, et al. Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey. Vaccine 2021 (published online Apr 27)

Simon P, Ho A, Shah MD, et al. Trends in mortality from COVID-19 and other leading causes of death among Latino vs White individuals in Los Angeles County, 2011-2020. JAMA (Research letter) 2021 (published online Jul 19)

Singer SR, Angulo FJ, Swerdlow DL, et al. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: a prospective cohort study. EClinicalMedicine 2021 (published online Nov 28)

Singh A, Khillan R, Mishra Y, et al. The safety profile of COVID-19 vaccinations in the United States. Am J Infect Control 2021 (published online Oct 23)

Sjogren L, Stenberg E, Thuccani M, et al. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—a cohort study. PLOS One 2021 (published online Oct 13)

Somekh I, Stein M, Karakis I, et al. Characteristics of SARS-CoV-2 infections in Israeli children during the circulation of different SARS-CoV-2 variants. JAMA Netw Open 2021;4(9):e2124343

Sonawane K, Lin YY, Damgacioglu H, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Netw Open 2021 Sep 17;4(9):e2124502

Soraas A, Bo R, Kalleberg KT, et al. Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw Open 2021 Jul 29;4(7):e2118717

Soucy JPR, Ghasemi A, Sturrock SL, et al. Trends in interregional travel to shopping malls and restaurants before and after differential COVID-19 restrictions in the Greater Toronto Area. JAMA Netw Open 2021 (published online Aug 31)

Spicer KB, Glick C, Cavanaugh AM, et al. Protective immunity after natural infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020. Int J Infect Dis 2021 (published online Oct 11)

Splinter MJ, Velek P, Ikram MK, et al. Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: a population-based cross-sectional study. PLOS Med 2021 (published online Nov 23)

Stein J, Fasold M, Daguerre KJ, et al. Use of an analytics and electronic health record–based approach for targeted COVID-19 vaccine outreach to marginalized populations. JAMA Oncol 2021 (published online Aug 19)

Stephenson E, Reynolds G, Botting RA, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med 2021 (published online Apr 20)

Stephenson KE, Le Gars M, Sadoff J, et al. Immunogenicity of the Ad26.COV2.S vaccine for COVID-19. JAMA 2021 (published online Mar 11)

Stockeler AM, Schuster P, Zimmermann M, et al. Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic. PLOS One 2021 (published online Nov 19)

Stokes AC, Lundberg DJ, Elo I, et al. COVID-19 and excess mortality in the United States: a county-level analysis. PLOS Med 2021 (published online May 20)

Suarez-Garcia I, Perales-Fraile I, Gonzalez-Garcia A, et al. In-hospital mortality among immunosuppressed patients with COVID-19: analysis from a national cohort in Spain. PLOS One 2021 (published online Aug 3)

Subramanian R, He Q, Pascual M. Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity. Proc Natl Acad Sci 2021 Mar 2;118(9):e2019716118

Sullivan PS, Siegler AJ, Shioda K, et al. SARS-CoV-2 cumulative incidence, United States, August-December 2020. Clin Infect Dis 2021 (published online Jul 10)

Sultanian P, Lundgren P, Stromsoe A, et al. Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest: a report from the Swedish Registry for Cardiopulmonary Resuscitation. Eur Heart J 2021 (published online Feb 5)

Taji L, Thomas D, Oliver MJ, et al. COVID-19 in patients undergoing long-term dialysis in Ontario. CMAJ 2021 (published online Feb 4)

Talbot HK, Martin ET, Gaaglani M, et al. Coronavirus disease 2019 (COVID-19) versus influenza in hospitalized adult patients in the United States: differences in demographic and severity indicators. Clin Infect Dis 2021 (published online May 29)

Talbot TR. COVID-19 vaccination of health care personnel as a condition of employment: a logical addition to institutional safety programs. JAMA (Viewpoint) 2021 (published online Jun 7)

Talita DS, Vizcaya D, Pistillo A, et al. 30-day outcomes of children and adolescents with COVID-19: an international experience. Pediatrics 2021 May 28:e2020042929

Tan AX, Hinman JA, Magid HS, et al. Association between income inequality and county-level COVID-19 cases and deaths in the US. JAMA Netw Open 2021 May 3;4(5):e218799

Tande AJ, Pollock BD, Shah ND, et al. Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening. Clin Infect Dis 2021 (published online Mar 10)

Tang P, Hasan MR, Chemaitelly H, et al. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar. Nat Med 2021 (published online Nov 2)

Tankere P, Cottenet J, Tubert-Bitter P, et al. Impact of COVID-19 and lockdowns on pulmonary embolism in hospitalized patients in France: a nationwide study. BMC Resp Res 2021 Nov 20;22(298)

Taquet M, Dercon Q, Luciano S, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Med 2021 (published online Sep 28)

Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021 (published online Apr 6)

Taquet M, Husain M, Geddes JR, et al. Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine. OSFPreprints 2021 (preprint) Apr 15

Tartof SY, Slezak JM, Fischer H, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet 2021 (published online Oct 4)

Tauffer J, Roma de Oliveira Konstantyner TC, Stockler de Almeida MC, et al. Impact of in-hospital infection with SARS-CoV-2 among inpatients at a university hospital. Am J Infect Control 2021 (published online Sep 19)

Temesgen Z, Burger CD, Baker J, et al. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med 2021 (published online Dec 1)

Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years—United States, January–March 2021. MMWR 2021 Apr 28;70

Teo I, Chay J, Cheung YB, et al. Healthcare worker stress, anxiety and burnout during the COVID-19 pandemic in Singapore: a 6-month multi-centre prospective study. PLOS One 2021 (published online Oct 22)

Teran RA, Walblay KA, Shane EL, et al. Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members—Chicago, Illinois, December 2020–March 2021. MMWR 2021 (published online Apr 21)

Tesfaw A, Arage G, Teshome F, et al. Community risk perception and barriers for the practice of COVID-19 prevention measures in Northwest Ethiopia: a qualitative study. PLOS One 2021 (published online Sep 24)

Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 2021 (published online Apr 15)

Thiruvengadam R, Awasthi A, Medigeshi G, et al. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Lancet Infect Dis 2021 (published online Nov 25)

Thomas SJ, Moreira Ed, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl J Med 2021 (published online Sep 15)

Thompson CN, Hughes S, Ngai S, et al. Rapid emergence and epidemiologic characteristics of the SARS-CoV-2 B.1.526 variant—New York City, Jan 1–Apr 5, 2021. MMWR 2021 May 5;70

Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight U.S. locations, December 2020–March 2021. MMWR 2021 Mar 29;70

Tleyjeh IM, Saddik B, AlSwaidan N, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLOS One 2021 (published online Dec 7)

Toh ZQ, Higgins RA, Do LA, et al. Persistence of SARS-CoV-2–specific IgG in children 6 months after infection, Australia. Emerg Infect Dis 2021 Aug;27(8)

Tomic A, Skelly DT, Ogbe A, et al. Divergent trajectories of antiviral memory after SARS-Cov-2 infection. Res Square (Preprint) 2021 (published online Jun 15)

Tong X, Xu X, Lv G, et al. Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China. BMC Infect Dis 2021 Apr 12;21:341

Torres AR, Johnson NP, Ellingson MK, et al. State laws permitting adolescent consent to human papillomavirus vaccination and rates of immunization. JAMA Pediatr 2021 (published online Nov 15)

Torres C, Ogbu-Nwobodo L, Alsan M, et al. Effect of physician-delivered COVID-19 public health messages and messages acknowledging racial inequity on Black and white adults' knowledge, beliefs, and practices related to COVID-19: a randomized clinical trial. JAMA Netw Open 2021 Jul 14;4(7):e2117115

Townsend JP, Hassler HB, Wang Z, et al. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Lancet Microbe 2021 (published online Oct 1)

Troxel AB, Petkova E, Goldfeld K, et al. Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis. JAMA Netw Open 2022 Jan 25;5(1):e2147331

Turner JS, Kim W, Kalaidina E, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature 2021 (published online May 24)

Twohig KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis 2021 (published online Aug 27)

Tworek A, Jaron K, Uszynska-Kaluza B, et al. Convalescent plasma treatment is associated with lower mortality and better outcomes in high risk COVID-19 patients—propensity score matched case-control study. Int J Infect Dis 2021 (published online Feb 15)

Tziolos N, Karofylakis E, Grigoropoulos I, et al. Real-life effectiveness and safety of baricitinib as adjunctive to standard-of-care treatment in hospitalized patients with severe COVID-19. Open Forum Infect Dis 2021 (published online Nov 22)

Uphoff EP, Lombardo C, Johnston G, et al. Mental health among healthcare workers and other vulnerable groups during the COVID-19 pandemic and other coronavirus outbreaks: a rapid systematic review. PLOS One 2021 (published online Aug 4)

Vacharathit V, Srichatrapimuk S, Manopwisedjaroen S, et al. SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile. Int J Infect Dis 2021 (published online Sep 15)

Van Dyke ME, Mendoza MC, Li W, et al. Racial and ethnic disparities in COVID-19 incidence by age, sex, and period among persons aged <25 years—16 U.S. jurisdictions, January 1–December 31, 2020. MMWR 2021 Mar 10;70

Velasquez SR, Jacques L, Dalal J, et al. The toll of COVID-19 on African children: a descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa. Int J Infect Dis 2021 (published online Jul 28)

Vella LA, Giles JR, Baxter AE, et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol 2021 Mar 2;6(57)

Vermillion MS, Murakami E, Ma B, et al. Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection. Sci Transl Med 2021 (published online Dec 30)

Videon TM, Rosati RJ, Landers SH, et al. COVID-19 infection rates early in the pandemic among full time clinicians in a home health care and hospice organization. Am J Infect Control 2021 (published online Oct 1)

Vohringer HS, Sanderson T, Sinnott M, et al. Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature 2021 (published online Oct 14)

Volz E, Mishra S, Chand M, et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 2021 (published online Mar 25)

Voysey M, Clemens SA, Madhi SA, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet 2021 (published online Feb 19)

Wahlgren C, Divanoglou A, Larsson M, et al. Rehabilitation needs following COVID-19: five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine 2021 (published online Dec 4)

Wainstock T, Yoles I, Sergienko R, et al. Prenatal maternal COVID-19 vaccination and pregnancy outcomes. Vaccine 2021 (published online Sep 7)

Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA (Viewpoint) 2021 (published online Feb 17)

Walker JL, Grint DJ, Strongman H, et al. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health 2021 Mar 11;21:484

Walter EB, Talaat KR, Sabharwal C, et al. Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age. N Engl J Med 2021 (published online Nov 9)

Wang L, Berger NA, Xu R, et al. Risks of SARS-CoV-2 breakthrough infection and hospitalization in fully vaccinated patients with multiple myeloma. Hemat 2021 (published Nov 23)

Wang L, Wang Q, Davis PB, et al. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry 2021 (published online Oct 5)

Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 2021 (published online Mar 8)

Wang QQ, Davis PB, Gurney ME, et al. COVID‐19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement 2021 (published online Feb 9)

Wang Y, Siesel C, Chen Y, et al. Severe acute respiratory syndrome coronavirus 2 transmission in Georgia, USA, February 1–July 13, 2020. Emerg Infect Dis 2021 (published online Aug 16)

Wang Z, Muecksch F, Schaefer-Babajew D, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 2021 (published online Jun 14)

Wang Z, Schmidt F, Nussenzweig MC. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021 Feb 10;32

Ward JL, Harwood R, Smith C, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med 2021 Dec 20;94(1034)

Washington NL, Gangavarapu K, Zeller M, et al. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States. Cell 2021 (published online Mar 30)

Washington NL, Gangavarapu K, Zeller M, et al. Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States. medRxiv (preprint) 2021 (published online Feb 7)

Weber DJ, Al-Tawfiq J, Babcock H, et al. Multisociety statement on COVID-19 vaccination as a condition of employment for healthcare personnel. Infect Control Hosp Epidemiol 2021 (published online Jul 13)

Wei SQ, Bilodeau-Bertrand M, Liu S, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ (published online Mar 19)

Weinhandl ED, Wetmore JB, Peng Y, et al. Initial effects of COVID-19 on patients with ESKD. J Am Soc Nephrol 2021 Apr;32(4)

Welsh KJ, Baumblatt J, Chege W, et al. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021 (published online Apr 30)

Whitaker HJ, Elgohari S, Rowe C, et al. Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021. J Infect 2021 (published online May 10)

Whitaker HJ, Tsang RSM, Byford R, et al. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups. J Infect 2022 (published online Jan 2)

Whiteman A, Wang A, McCain K, et al. Demographic and social factors associated with COVID-19 vaccination initiation among adults aged ≥65 years—United States, December 14, 2020–April 10, 2021. MMWR 2021 May 11;70

Whittaker C, Watson OJ, Alvarez-Moreno C, et al. Understanding the potential impact of different drug properties on SARS-CoV-2 transmission and disease burden: a modelling analysis. Clin Infect Dis 2021 (published online Sep 21)

Wibmer CK, Ayres F, Hermanus T, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med (Brief communication2021 (published online Mar 2)

Wiemken TL, Niemotka SL, Clarke JA, et al. Estimating pediatric cases of COVID-19 over time in the United States: filling in a gap in public use data. Am J Infect Control 2021 (published online Oct 27)

Wilson NM, Marks GB, Eckhardt A, et al. The effect of respiratory activity, non‐invasive respiratory support and facemasks on aerosol generation and its relevance to COVID‐19. Anaesthesia 2021 (published online Mar 30)

Wimberly CE, Towry L, Davis E, et al. SARS-CoV-2 vaccine acceptability among caregivers of childhood cancer survivors. Pediatr Blood Cancer 2021 (published online Nov 17)

Witberg G, Barda N, Hoss S, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med 2021 (published online Oct 6)

Woldemeskel BA, Karaba AH, Garliss CC, et al. The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with HIV. Clin Infect Dis 2021 (published online Jul 22)

Wong WHS, Leung D, Chua GT, et al. Adolescents’ attitudes to the COVID-19 vaccination. Vaccine 2022 (published online Jan 12)

Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics 2021 Oct 1;148(4)

Woodworth KR, Moulia D, Collins JP, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 Years — United States, November 2021. MMWR Morb Mortal Wkly Rep 2021 Nov 12;70:1579–1583

Woolf SH, Chapman DA, Sabo RT, et al. Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021. JAMA (Research letter) 2021 (published online Apr 2)

Wortham JM, Meador SA, Hadler JL, et al. Census tract socioeconomic indicators and COVID-19-associated hospitalization rates—COVID-NET surveillance areas in 14 states, March 1–April 30, 2020. PLOS One 2021 (published online Sep 24)

Writing Committee for the REMAP-CAP Investigators. Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19. JAMA (published online Oct 4)

Wu K, Werner AP, Koch M, et al. Serum neutralizing activity elicited by mRNA-1273 vaccine—preliminary report. N Engl J Med (Letter) 2021 (published online Feb 17)

Wu P, Liu F, Chang Z, et al. Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2. Clin Infect Dis 2021 (published online Mar 27)

Wu X, Wang Z, He Z, et al. A follow-up study shows that recovered patients with re-positive PCR test in Wuhan may not be infectious. BMC Med 2021 Mar 15;19:77

Xie X, Liu Y, Liu J, et al. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med 2021 Feb 8:599

Yakusheva O, Broek-Altenburg EVD, Brekke G, et al. Lives saved and lost in the first six month of the US COVID-19 pandemic: a retrospective cost-benefit analysis. PLOS One 2022 (published online Jan 21)

Yang HS, Costa V, Racine-Brzostek SE, et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open 2021 Mar 22;4(3):e214302

Yang J, Zhang Q, Cao Z, et al. The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City. Chaos 2021 (published online Feb 9)

Yang Q, Saldi TK, Gonzales PK, et al. Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities. Proc Natl Acad Sci 2021 May 25;118(21):e2104547118

Yelagandula R, Bykov A, Vogt A, et al. Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq. Nat Commun 2021 (published online May 25)

Yin S, Barnes K, Fisher R, et al. COVID-19 case rates in transitional kindergarten through grade 12 schools and in the community—Los Angeles County, California, September 2020–March 2021. MMWR Morb Mortal Wkly Rep 2021 Sep 2;70:1220–2

Young BC, Eyre DW, Kendrick S, et al. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial. Lancet 2021 (published online Sep 14)

Young BE, Seppo AE, Diaz N, et al. Association of human milk antibody induction, persistence, and neutralizing capacity with SARS-CoV-2 infection vs mRNA vaccination. JAMA Pediatr 2021 (published online Nov 10)

Yu LM, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet 2021 (published online Aug 10)

Zambrano LD, Newhams MM, Olson SM, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years—United States, July–December 2021. MMWR Morb Mortal Wkly Rep 2022 (published online Jan 7)

Zein S, Abdallah SB, Al-Smadi A, et al. Factors associated with the unwillingness of Jordanians, Palestinians and Syrians to be vaccinated against COVID-19. PLOS Negl Trop Dis 2021 (published online Dec 9)

Zhang L, Richards A, Barrasa NI, et al. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci 2021 May 25;118(2):e2105968118

Zhang W, Davis BD, Chen SS, et al. Emergence of a novel SARS-CoV-2 variant in Southern California. JAMA (Research letter) 2021 (published online Feb 11)

Zhang Z, Ai G, Chen L, et al. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis. BMC Infect Dis 2021 Aug 3;21(738)

Zhao M, Holtz D, Aral S. Interdependent program evaluation: Geographic and social spillovers in COVID-19 closures and reopenings in the United States. Sci Adv 2021 Jul 28;7(31)

Zheng C, Shao W, Chen X, et al. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis 2021 (published online Nov 16)

Zhong D, Xiao S, Debes AK, et al. Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection. JAMA Netw Open 2021 (published online Nov 1)

Zhong Y, Wang K, Zhu Y, et al. Ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Travel Med Infect Dis 2021 (published online Nov 8)

Zimmerman KO, Brookhart MA, Kalu IC, et al. Community SARS-CoV-2 surge and within-school transmission. Pediatrics 2021 (published online Sep 15)

Zinszer K, McKinnon B, Bourque N, et al. Seroprevalence of SARS-CoV-2 antibodies among children in school and day care in Montreal, Canada. JAMA Netw Open 2021 Nov 23;4911):e2135975 

Zubiago J, Wurcel AG, Guardado R, et al. Barriers to COVID-19 testing reported by health care workers during the first wave at an academic center in Boston, MA. Infect Control Hosp Epidemiol 2021 (published online Sep 21)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»